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Overview 
Internal and external respiration 
 (mt) Mitochondrial catabolic respiration 
JkO2 is the O2 consumption in the oxidation of 
fuel substrates (electron donors) and 
reduction of O2 catalysed by the electron 
transfer system ETS, which drives the 
protonmotive force pmF. JkO2 excludes 
mitochondrial residual oxygen consumption, 
mt-Rox (). 
 (ce) Cell respiration JrO2 is internal cellular 
O2 consumption, taking into account all 
chemical reactions r that consume O2 in the 
cells. Catabolic cell respiration is the O2 
consumption associated with catabolic 
pathways in the cell, including mitochondrial 
(mt) catabolism, and: mt-Rox (); non-mt O2 
consumption by catabolic reactions, 
particularly peroxisomal oxidases and 
microsomal cytochrome P450 systems (); 
non-mt Rox by reactions unrelated to 
catabolism (). 
 (ext) External respiration balances internal respiration at steady-state, including 
extracellular Rox () and aerobic respiration by the microbiome ().  
 O2 is transported from the environment across the respiratory cascade, i.e., circulation between 
tissues and diffusion across cell membranes, to the intracellular compartment. The respiratory 
quotient RQ is the molar CO2/O2 exchange ratio; when combined with the respiratory nitrogen 
quotient N/O2 (mol N given off per mol O2 consumed), the RQ reflects the proportion of 
carbohydrate, lipid and protein utilized in cell respiration during aerobically balanced steady-
states. Bicarbonate and CO2 are transported in reverse to the extracellular milieu and the 
organismic environment. Hemoglobin provides the molecular paradigm for the combination of O2 
and CO2 exchange, as do lungs, gills, the skin and other surfaces on the morphological level.  
 Respiratory states are defined in Table 1. Rates are illustrated in Figure 5. Consult Tables 4 
and  8 for terms and symbols. 
 
Updates: 
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Abstract 
 
As the knowledge base and importance of 
mitochondrial physiology to evolution, 
health and disease expands, the necessity 
for harmonizing the terminology 
concerning mitochondrial respiratory 
states and rates has become increasingly 
apparent. The chemiosmotic theory 
establishes the mechanism of energy 
transformation and coupling in oxidative 
phosphorylation. The unifying concept of 
the protonmotive force provides the 
framework for developing a consistent 
theoretical foundation of mitochondrial 
physiology and bioenergetics. We follow 
the latest SI guidelines and those of the 
International Union of Pure and Applied 
Chemistry (IUPAC) on terminology in 
physical chemistry, extended by 
considerations of open systems and 
thermodynamics of irreversible 
processes. The concept-driven 
constructive terminology incorporates 
the meaning of each quantity and aligns 
concepts and symbols with the 
nomenclature of classical bioenergetics. 
We endeavour to provide a balanced view 
of mitochondrial respiratory control and 
a critical discussion on reporting data of 
mitochondrial respiration in terms of 
metabolic flows and fluxes. Uniform 
standards for evaluation of respiratory 
states and rates will ultimately contribute 
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to reproducibility between laboratories 
and thus support the development of data 
repositories of mitochondrial respiratory 
function in species, tissues, and cells. 
Clarity of concept and consistency of 
nomenclature facilitate effective 
transdisciplinary communication, 
education, and ultimately further 
discovery. 
 
Keywords―MitoPedia: Respiratory states • SI 
- The International System of Units • IUPAC • 
Coupling control • Mitochondrial 
preparations • Protonmotive force • 
Uncoupling • Oxidative phosphorylation • 
Phosphorylation efficiency • Electron 
transfer-pathway • LEAK-respiration • 
Residual oxygen consumption • 
Normalization of rate • Flow • Flux • Flux 
control ratio • Mitochondrial marker •  Cell 
count • Oxygen 
 
 
Executive summary 
 
In view of the broad implications for health 
care, mitochondrial researchers face an 
increasing responsibility to disseminate 
their fundamental knowledge and novel 
discoveries to a wide range of stakeholders 
and scientists beyond the group of 
specialists. This requires implementation of 
a commonly accepted terminology within 
the discipline and standardization in the 
translational context. Authors, reviewers, 
journal editors, and lecturers are challenged 
to collaborate with the aim to harmonize the 
nomenclature in the growing field of 
mitochondrial physiology and bioenergetics, 
from evolutionary biology and comparative 
physiology to mitochondrial medicine. In the 
present communication we focus on the 
following concepts in mitochondrial 
physiology: 
 
 1. Aerobic respiration is the O2 flux in 
catabolic reactions coupled to 
phosphorylation of ADP to ATP, and O2 flux 
in a variety of O2 consuming reactions apart 
from oxidative phosphorylation (OXPHOS). 
Coupling in OXPHOS is mediated by the 
translocation of protons across the 
mitochondrial inner membrane (mtIM) 
through proton pumps generating or 
utilizing the protonmotive force that is 
maintained between the mitochondrial 
matrix and intermembrane compartment or 
outer mitochondrial space. Compartmental 
coupling depends on ion translocation 
across a semipermeable membrane, which is 
defined as vectorial metabolism and 
distinguishes OXPHOS from cytosolic 
fermentation as counterparts of cellular core 
energy metabolism (Overview). Cell 
respiration is thus distinguished from 
fermentation: (1) Electron acceptors are 
supplied by external respiration for the 
maintenance of redox balance, whereas 
fermentation is characterized by an internal 
electron acceptor produced in intermediary 
metabolism. In aerobic cell respiration, 
redox balance is maintained by O2 as the 
electron acceptor. (2) Compartmental 
coupling in vectorial OXPHOS contrasts to 
scalar substrate-level phosphorylation in 
fermentation. 
 
 2. When measuring mitochondrial 
metabolism, the contribution of 
fermentation and other cytosolic 
interactions must be excluded from analysis 
by disrupting the barrier function of the 
plasma membrane. Selective removal or 
permeabilization of the plasma membrane 
yields mitochondrial preparations—
including isolated mitochondria, tissue and 
cell preparations—with structural and 
functional integrity. Subsequently, 
extramitochondrial concentrations of 
oxidizable ‘fuel’ substrates, as well as ADP, 
ATP, inorganic phosphate, and cations 
including H+ can be controlled to determine 
mitochondrial function under a set of 
conditions defined as respiratory states. We 
strive to incorporate an easily recognized 
and understood concept-driven terminology 
of bioenergetics with explicit terms and 
symbols that define the nature of respiratory 
states. 
 
 3. Mitochondrial coupling states are 
defined according to the control of 
respiratory oxygen flux by the protonmotive 
force pmF, in an interaction of the electron 
transfer system generating the pmF and the 
phosphorylation system utilizing the pmF. 
Capacities of OXPHOS and electron transfer 
are measured at kinetically-saturating 
concentrations of fuel substrates, ADP and 
inorganic phosphate, and O2, or at optimal 
uncoupler concentrations, respectively, in 
 
 
  Consortium Communication 
4 of 44 Gnaiger E et al ― MitoEAGLE Task Group (2020) Bioenerg Commun 2020.1 
 
the absence of Complex IV inhibitors such as 
NO, CO, or H2S. Respiratory capacity is a 
measure of the upper limit of the rate of 
respiration; it depends on the fuel substrate 
type undergoing oxidation in a 
mitochondrial pathway, and provides 
reference values for the diagnosis of health 
and disease. Evaluation of the impact of 
evolutionary background, age, gender and 
sex, lifestyle and environment represents a 
major challenge for mitochondrial 
respiratory physiology and pathology. 
 
 4. Incomplete tightness of coupling, i.e., 
some degree of uncoupling relative to the 
mitochondrial pathway-dependent coupling 
stoichiometry, is a characteristic of energy-
transformations across membranes. 
Uncoupling or dyscoupling are caused by 
physiological, pathological, toxicological, 
pharmacological and environmental 
conditions that exert an influence not only on 
the proton leak and cation cycling, but also 
on proton slip within the proton pumps and 
the structural integrity of the mitochondria. 
A more loosely coupled state is induced by 
stimulation of mitochondrial superoxide 
formation and the bypass of proton pumps. 
In addition, the use of protonophores 
represents an experimental uncoupling 
intervention to assess the transition from a 
well-coupled to a noncoupled state of 
mitochondrial respiration. 
 
 5. Respiratory oxygen consumption rates 
have to be carefully normalized to enable 
meta-analytic studies beyond the question of 
a particular experiment. Therefore, all raw 
data on rates and variables for normalization 
should be published in an open access data 
repository. Normalization of rates for: (1) 
the number of objects (cells, organisms); (2) 
the volume or mass of the experimental 
sample; and (3) the concentration of 
mitochondrial markers in the instrumental 
chamber are sample-specific normalizations, 
which are distinguished from system-
specific normalization for the volume of the 
instrumental chamber (the measuring 
system). 
 
 6. The consistent use of terms and 
symbols facilitates transdisciplinary 
communication and will support the further 
development of a collaborative database on 
bioenergetics and mitochondrial physiology. 
 
Box 1: In brief – Mitochondria and 
bioblasts 
 
‘For the physiologist, mitochondria 
afforded the first opportunity for an 
experimental approach to structure-
function relationships, in particular those 
involved in active transport, vectorial 
metabolism, and metabolic control 
mechanisms on a subcellular level’ 
(Ernster and Schatz 1981) [38]. 
 
Mitochondria are oxygen-consuming 
electrochemical generators (Figure 1). They 
evolved from the endosymbiotic 
alphaproteobacteria which became 
integrated into a host cell related to Asgard 
Archaea [85; 72; 117]. Richard Altmann 
described the ‘bioblasts’ in 1894 [1], which 
include not only mitochondria as presently 
defined, but also symbiotic and free-living 
bacteria. The word ‘mitochondria’ (Greek 
mitos: thread; chondros: granule) was 
introduced by Carl Benda in 1898 [4]. 
Mitochondrion is singular and mitochondria 
is plural. Abbreviation: mt, as generally used 
in mtDNA. 
 Contrary to past textbook dogma, which 
describes mitochondria as individual 
organelles, mitochondria form dynamic 
networks within eukaryotic cells. 
Mitochondrial movement is supported by 
microtubules. Mitochondrial size and 
number can change in response to energy 
requirements of the cell via processes known 
as fusion and fission; these interactions 
allow mitochondria to communicate within a 
network [18]. Mitochondria can even 
traverse cell boundaries in a process known 
as horizontal mitochondrial transfer [133]. 
Another defining morphological 
characteristic of mitochondria is the double 
membrane. The mitochondrial inner 
membrane, mtIM, forms dynamic tubular to 
disk-shaped cristae that separate the 
mitochondrial matrix, i.e., the negatively 
charged internal mitochondrial 
compartment, from the intermembrane 
space; the latter being enclosed by the 
mitochondrial outer membrane, mtOM, and 
positively charged with respect to the matrix.  
 Intracellular stress factors may cause 
shrinking or swelling of the mitochondrial 
matrix that can ultimately result in 
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permeability transition mtPT [77]. The mtIM 
contains the non-bilayer phospholipid 
cardiolipin, which is also involved in the 
mtOM [47] but is not present in any other 
eukaryotic cellular membrane. Cardiolipin 
has many regulatory functions [101]; it 
promotes and stabilizes the formation of 
supercomplexes (SCInIIInIVn) based on 
dynamic interactions between specific 
respiratory complexes [58; 80; 87], and it 
supports proton transfer on the mtIM from 
the electron transfer system to F1FO-ATPase 
(ATP synthase [144]). The mtIM is plastic 
and exerts an influence on the functional 
properties of incorporated proteins [135].  
 Mitochondria constitute the structural 
and functional elementary components of 
cell respiration. Aerobic respiration is the 
reduction of molecular oxygen by electron 
transfer coupled to electrochemical proton 
translocation across the mtIM. In the process 
of OXPHOS, the catabolic reaction sequence 
of oxygen consumption is electrochemically 
coupled to the transformation of energy in 
the phosphorylation of ADP to adenosine 
triphosphate, ATP [92; 93]. Mitochondria are 
the powerhouses of the cell that contain the 
machinery of the OXPHOS-pathways, 
including transmembrane respiratory 
complexes (proton pumps with FMN, Fe-S 
and cytochrome b, c, aa3 redox systems); 
alternative dehydrogenases and oxidases; 
the coenzyme ubiquinone, Q; F1FO-ATPase; 
the enzymes of the tricarboxylic acid cycle, 
TCA, fatty acid and amino acid oxidation; 
transporters of ions, metabolites and co-
factors; iron/sulphur cluster synthesis; and 
mitochondrial kinases related to catabolic 
pathways. TCA cycle intermediates are vital 
precursors for macromolecule biosynthesis 
[30]. The mitochondrial proteome comprises 
over 1,200 types of protein [13; 14], mostly 
encoded by nuclear DNA, nDNA, with a 
variety of functions, many of which are 
relatively well known, e.g., proteins 
regulating mitochondrial biogenesis or 
apoptosis, while others are still under 
investigation, or need to be identified, e.g., 
mtPT pore and alanine transporter. The 
mammalian mitochondrial proteome can be 
used to discover and characterize the genetic 
basis of mitochondrial diseases [102; 142]. 
 Numerous cellular processes are 
orchestrated by a constant crosstalk 
between mitochondria and other cellular 
components. For example, the crosstalk 
between mitochondria and the endoplasmic 
reticulum is involved in the regulation of 
calcium homeostasis, cell division, 
autophagy, differentiation, and anti-viral 
signaling [98]. Mitochondria contribute to 
the formation of peroxisomes, which are 
hybrids of mitochondrial and ER-derived 
precursors [131]. Cellular mitochondrial 
homeostasis (mitostasis) is maintained 
through regulation at transcriptional, post-
translational and epigenetic levels [81; 82], 
resulting in dynamic regulation of 
mitochondrial turnover by biogenesis of new 
mitochondria and removal of damaged 
mitochondria by fusion, fission and 
mitophagy [128]. Cell signalling modules 
contribute to homeostatic regulation 
throughout the cell cycle or even cell death 
by activating proteostatic modules, e.g., the 
ubiquitin-proteasome and autophagy-
lysosome/vacuole pathways; specific 
proteases like LON, and genome stability 
modules in response to varying energy 
demands and stress cues [109]. In addition, 
several post-translational modifications, 
including acetylation and nitrosylation, are 
capable of influencing the bioenergetic 
response, with clinically significant 
implications for health and disease [17]. 
 Mitochondria of higher eukaryotes 
typically maintain several copies of their 
own circular genome known as 
mitochondrial DNA, mtDNA (hundred to 
thousands per cell [27]), which is maternally 
inherited in many species. However, 
biparental mitochondrial inheritance is 
documented in some exceptional cases in 
humans [83], is widespread in birds, fish, 
reptiles and invertebrate groups, and is even 
the norm in some bivalve taxonomic groups 
[9; 140]. 
 The mitochondrial genome of the 
angiosperm Amborella contains a record of 
six mitochondrial genome equivalents 
acquired by horizontal transfer of entire 
genomes, two from angiosperms, three from 
algae and one from mosses [114]. In 
unicellular organisms, i.e., protists, the 
structural organization of mitochondrial 
genomes is highly variable and includes 
circular and linear DNA [145]. While some of 
the free-living flagellates exhibit the largest 
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known gene coding capacity, e.g., jakobid 
Andalucia godoyi mtDNA codes for 106 genes 
[12], some protist groups, e.g., alveolates, 
possess mitochondrial genomes with only 
three protein-coding genes and two rRNAs 
[42]. The complete loss of mitochondrial 
genome is observed in the highly reduced 
mitochondria of Cryptosporidium species 
[83]. Reaching the final extreme, the 
microbial eukaryote, oxymonad 
Monocercomonoides, has no mitochondrion 
whatsoever and lacks all typical nuclear-
encoded mitochondrial proteins, showing 
that while in 99 % of organisms 
mitochondria play a vital role, this organelle 
is not indispensable [65]. 
 In vertebrates, but not all invertebrates, 
mtDNA is compact (16.5 kB in humans) and 
encodes 13 protein subunits of the 
transmembrane respiratory Complexes CI, 
CIII, CIV and ATP synthase (F1FO-ATPase), 22 
tRNAs, and two ribosomal RNAs. Additional 
gene content has been suggested to include 
microRNAs, piRNA, smithRNAs, repeat 
associated RNA, long noncoding RNAs, and 
even additional proteins or peptides [23; 35; 
74; 111]. The mitochondrial genome 
requires nuclear-encoded mitochondrially 
targeted proteins, e.g., TFAM, for its 
maintenance and expression [110]. The 
nuclear and the mitochondrial genomes 
encode peptides of the membrane spanning 
redox pumps (CI, CIII and CIV) and F1FO-
ATPase, leading to strong constraints in the 
coevolution of both genomes [6]. 
 Given the multiple roles of mitochondria, 
it is perhaps not surprising that  
mitochondrial dysfunction is associated with 
a wide variety of genetic and degenerative 
diseases [41]. Robust mitochondrial function 
is supported by physical exercise and caloric 
balance, and is central for sustained  
Figure 1. Cell respiration and oxidative phosphorylation (OXPHOS) 
Mitochondrial respiration is the oxidation of fuel substrates (electron donors) with electron 
transfer to O2 as the electron acceptor. For explanation of symbols see also Overview.  
 (a) Respiration of living cells: Extramitochondrial catabolism of macrofuels and uptake of 
small molecules by the cell provide the mitochondrial fuel substrates. Dashed arrows indicate 
the connection between the redox proton pumps (respiratory Complexes CI, CIII and CIV) and 
the transmembrane protonmotive force pmF. Coenzyme Q (Q) and the cytochromes b, c, and 
aa3 are redox systems of the mitochondrial inner membrane, mtIM. Glycerol-3-phosphate, Gp. 
 (b) Respiration in mitochondrial preparations: The mitochondrial electron transfer system 
ETS is (1) fuelled by diffusion and transport of substrates across the mtOM and mtIM, and in 
addition consists of the (2) matrix-ETS, and (3) membrane-ETS. Electron transfer converges at 
the N-junction, and from CI, CII and electron transferring flavoprotein complex CETF at the Q-
junction. Unlabeled arrows converging at the Q-junction indicate additional ETS-sections with 
electron entry into Q through glycerophosphate dehydrogenase, dihydroorotate 
dehydrogenase, proline dehydrogenase, choline dehydrogenase, and sulfide-ubiquinone 
oxidoreductase. The dotted arrow indicates the branched pathway of oxygen consumption by 
alternative quinol oxidase AOX. ET-pathways are coupled to the phosphorylation-pathway. 
The H+pos/O2 ratio is the outward proton flux from the matrix space to the positively (pos) 
charged vesicular compartment, divided by catabolic O2 flux in the NADH-pathway. The 
H+neg/P» ratio is the inward proton flux from the inter-membrane space to the negatively (neg) 
charged matrix space, divided by the flux of phosphorylation of ADP to ATP. These 
stoichiometries are not fixed because of ion leaks and proton slip. Moreover, the H+neg/P» ratio 
is linked to the F1FO-ATPase c-ring stoichiometry, which is species-dependent and defines the 
bioenergetic cost of P». Modified from [78; 116]. 
 (c) OXPHOS-coupling: The H+ circuit couples O2 flux through the catabolic ET-pathway JkO2 
to flux through the phosphorylation-pathway JP» converting ADP to ATP. 
 (d) Phosphorylation-pathway catalyzed by the proton pump F1FO-ATPase (ATP synthase), 
adenine nucleotide translocase ANT, and inorganic phosphate carrier PiC. The H+neg/P» 
stoichiometry is the sum of the coupling stoichiometry in the F1FO-ATPase reaction (-2.7 H+pos 
from the positive intermembrane space, 2.7 H+neg to the matrix, i.e., the negative compartment) 
and the proton balance in the translocation of ADP3-, ATP4- and Pi2- (negative for substrates). 
Modified from [54]. 
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metabolic health throughout life. Therefore, 
a more consistent set of definitions for 
mitochondrial physiology will increase our 
understanding of the etiology of disease and 
improve the diagnostic repertoire of 
mitochondrial medicine with a focus on 
protective medicine, evolution, lifestyle, 
environment, and healthy aging. 
 
 
1. Introduction 
 
Mitochondria are the powerhouses of the cell 
with numerous morphological, 
physiological, molecular, and genetic 
functions (Box 1). Every study of 
mitochondrial health and disease faces 
Evolution, Age, Gender and sex, Lifestyle, 
and Environment (MitoEAGLE) as essential 
background conditions intrinsic to the 
individual person or cohort, species, tissue 
and to some extent even cell line. As a large 
and coordinated group of laboratories and 
researchers, the mission of the global 
MitoEAGLE Network is to generate the 
necessary scale, type, and quality of 
consistent data sets and conditions to 
address this intrinsic complexity. 
Harmonization of experimental protocols 
and implementation of a quality control and 
data management system are required to 
interrelate results gathered across a 
spectrum of studies and to generate a 
rigorously monitored database focused on 
mitochondrial respiratory function. In this 
way, researchers from a variety of 
disciplines can compare their findings using 
clearly defined and accepted international 
standards. 
 With an emphasis on quality of research, 
published data can be useful far beyond the 
specific question of a particular experiment. 
For example, collaborative data sets support 
the development of open-access databases 
such as those for National Institutes of 
Health sponsored research in genetics, 
proteomics, and metabolomics. Indeed, 
enabling meta-analysis is the most economic 
way of providing robust answers to 
biological questions [25]. However, the 
reproducibility of quantitative results 
depend on accurate measurements under 
strictly-defined conditions. Likewise, 
meaningful interpretation and comparability 
of experimental outcomes requires 
harmonization of protocols between 
research groups at different institutes. In 
addition to quality control, a conceptual 
framework is also required to standardise 
and harmonise terminology and 
methodology. Vague or ambiguous jargon 
can lead to confusion and may convert 
valuable signals to wasteful noise [100]. For 
this reason, measured values must be 
expressed in standard units for each 
parameter used to define mitochondrial 
respiratory function. A consensus on 
fundamental nomenclature and conceptual 
coherence, however, is missing in the 
expanding field of mitochondrial physiology. 
To fill this gap, the present communication 
provides an in-depth review on 
harmonization of nomenclature and 
definition of technical terms, which are 
essential to improve the awareness of the 
intricate meaning of current and past 
scientific vocabulary. This is important for 
documentation and integration into data 
repositories in general, and quantitative 
modelling in particular [3].  
 In this review, we focus on coupling states 
and fluxes through metabolic pathways of 
aerobic energy transformation in 
mitochondrial preparations in the attempt to 
establish a conceptually-oriented 
nomenclature in bioenergetics and 
mitochondrial physiology in a series of 
communications, prepared in the frame of 
the EU COST Action MitoEAGLE open to 
global bottom-up input. 
 
2. Coupling states and rates in 
mitochondrial preparations 
 
‘Every professional group develops its own 
technical jargon for talking about matters 
of critical concern ... People who know a 
word can share that idea with other 
members of their group, and a shared 
vocabulary is part of the glue that holds 
people together and allows them to create 
a shared culture’ (Miller 1991) [91]. 
 
2.1. Cellular and mitochondrial respiration 
 
2.1.1. Aerobic and anaerobic catabolism 
and ATP turnover: In respiration, electron 
transfer is coupled to the phosphorylation of 
ADP to ATP, with energy transformation 
 
 
BEC 2020.1 doi:10.26124/bec:2020-0001.v1  
www.bioenergetics-communications.org 9 of 44 
 
mediated by the protonmotive force, pmF 
(Figure 2). Anabolic reactions are coupled to 
catabolism, both by ATP as the intermediary 
energy currency and by small organic 
precursor molecules as building blocks for 
biosynthesis [30]. Glycolysis involves 
substrate-level phosphorylation of ADP to 
ATP in fermentation without utilization of 
O2, studied mainly in living cells and 
organisms. Many cellular fuel substrates are 
catabolized to acetyl-CoA or to glutamate, 
and further electron transfer reduces 
nicotinamide adenine dinucleotide to NADH 
or flavin adenine dinucleotide to FADH2. 
Subsequent mitochondrial electron transfer 
to O2 is coupled to proton translocation for 
the control of the pmF and phosphorylation 
of ADP (Figure 1b and 1c). In contrast, 
extramitochondrial oxidation of odd chain 
fatty acids, very long chain fatty acids, and 
some amino acids proceeds partially in 
peroxisomes without coupling to ATP 
production: acyl-CoA oxidase catalyzes the 
oxidation of FADH2 with electron transfer to 
O2; amino acid oxidases oxidize flavin 
mononucleotide FMNH2 or FADH2 (Figure 
1a). 
 The plasma membrane separates the 
intracellular compartment including the 
cytosol, nucleus, and organelles from the 
extracellular environment. Cell membranes 
include the plasma membrane and 
organellar membranes. The plasma 
membrane consists of a lipid bilayer with 
embedded proteins and attached organic 
molecules that collectively control the 
selective permeability of ions, organic 
molecules, and particles across the cell 
boundary. The intact plasma membrane 
prevents the passage of many water-soluble 
mitochondrial substrates and inorganic 
ions—such as succinate, adenosine 
diphosphate (ADP) and inorganic phosphate 
(Pi) that must be precisely controlled at 
kinetically-saturating concentrations for the 
analysis of mitochondrial respiratory 
capacities (Figure 2). Respiratory capacities 
delineate―comparable to channel capacity 
in information theory [123]―the upper 
boundary of the rate of O2 consumption 
measured in defined respiratory states. The 
intact plasma membrane limits the scope of 
investigations into mitochondrial 
respiratory function in living cells, despite 
the activity of solute carriers, e.g., the 
sodium-dependent dicarboxylate 
transporter SLC13A3 and the sodium-
dependent phosphate transporter SLC20A2, 
which transport specific metabolites across 
the plasma membrane of various cell types, 
and the availability of plasma membrane-
permeable succinate [37]. These limitations 
are overcome by the use of mitochondrial 
preparations. 
 
2.1.2. Specification of biochemical dose 
and exposure: Substrates, uncouplers, 
inhibitors, and other chemical reagents are 
titrated to analyse cellular and 
mitochondrial function. Nominal 
concentrations of these substances are 
usually reported as initial amount of 
substance concentration [mol∙L-1] in the 
incubation medium.  
 Kinetically-saturating conditions are 
evaluated by substrate kinetics to obtain the 
maximum reaction velocity or maximum 
pathway flux, in contrast to solubility-
saturated conditions. When aiming at the 
measurement of kinetically-saturated 
processes—such as OXPHOS-capacities—
the concentrations for substrates can be 
chosen according to half-saturating 
substrate concentrations c50, for metabolic 
pathways, or the Michaelis constant Km, for 
enzyme kinetics. In the case of hyperbolic 
kinetics, only 80 % of maximum respiratory 
capacity is obtained at a substrate 
Figure 2. Four-compartment model of 
oxidative phosphorylation 
Respiratory states (ET, OXPHOS, LEAK; 
Table 1) and corresponding rates (E, P, L) 
are connected by the protonmotive force, 
pmF. (1) ET-capacity E is partitioned into (2) 
dissipative LEAK-respiration L, when the 
Gibbs energy change of catabolic O2 flux is 
irreversibly lost, (3) net OXPHOS-capacity 
(P-L), with partial conservation of the 
capacity to perform work, and (4) the ET-
excess capacity (E-P). Modified from [54]. 
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concentration of four times the c50, whereas 
substrate concentrations of 5, 9, 19 and 49 
times the c50 are theoretically required for 
reaching 83, 90, 95 or 98 % of the maximal 
rate [51].  
 Other reagents are chosen to inhibit or 
alter a particular process. The amount of 
these chemicals in an experimental 
incubation is selected to maximize effect, 
avoiding unacceptable off-target 
consequences that would adversely affect 
the data being sought. Specifying the amount 
of substance in an incubation as nominal 
concentration in the aqueous incubation 
medium can be ambiguous [33], particularly 
for cations (TPP+; fluorescent dyes such as 
safranin, TMRM [22]) and lipophilic 
substances (oligomycin, uncouplers, 
permeabilization agents [32]), which 
accumulate in the mitochondrial matrix or 
on biological membranes, respectively. 
Generally, dose can be specified per unit of 
biological sample, i.e., (nominal moles of 
xenobiotic)/(number of cells) [mol∙x-1] or, as 
appropriate, per mass of biological sample 
[mol∙kg-1]. This approach to specification of 
dose provides a scalable parameter that can 
be used to design experiments, help 
interpret a wide variety of experimental 
results, and provide absolute information 
that allows researchers worldwide to make 
the most use of published data [33]. 
Exposure includes the additional dimension 
of time in contact with a particular dose. 
 
2.2. Mitochondrial preparations 
 
Mitochondrial preparations are defined as 
either isolated mitochondria or tissue and 
cell preparations in which the barrier 
function of the plasma membrane is 
disrupted. Since this entails the loss of cell 
viability, mitochondrial preparations are not 
studied in vivo. In contrast to isolated 
mitochondria and tissue homogenate 
preparations, mitochondria in 
permeabilized tissues and cells are in situ 
relative to the plasma membrane. When 
studying mitochondrial preparations, 
substrate-uncoupler-inhibitor-titration 
(SUIT) protocols are used to establish 
respiratory Coupling Control States (CCS) 
and Pathway Control States (PCS) that 
provide reference values for various output 
variables (Table 1). Physiological conditions 
in vivo deviate from these experimentally 
obtained states; this is because kinetically-
saturating concentrations, e.g., of ADP, 
oxygen (O2; dioxygen) or fuel substrates, 
may not apply to physiological intracellular 
conditions. Further information is obtained 
in studies of kinetic responses to variations 
in fuel substrate concentrations, [ADP], or 
[O2] in the range between kinetically-
saturating concentrations and anoxia [51]. 
 The cholesterol content of the plasma 
membrane is high compared to 
mitochondrial membranes [70]. Therefore, 
mild detergents—such as digitonin and 
saponin—can be applied to selectively 
permeabilize the plasma membrane via 
interaction with cholesterol; this allows free 
exchange of organic molecules and inorganic 
ions between the cytosol and the immediate 
cell environment, while maintaining the 
integrity and localization of organelles, 
cytoskeleton, and the nucleus. Application of 
permeabilization agents (mild detergents or 
toxins) leads to washout of cytosolic marker 
enzymes—such as lactate dehydrogenase—
and results in the complete loss of cell 
viability (tested by nuclear staining using 
plasma membrane-impermeable dyes), 
while mitochondrial function remains intact 
(tested by cytochrome c stimulation of 
respiration). 
 Digitonin concentrations have to be 
optimized according to cell type, particularly 
since mitochondria from cancer cells contain 
significantly higher contents of cholesterol in 
both membranes [2]. For example, a dose of 
digitonin per cell of 8 fmol∙x-1 [10 pg∙x-1; 10 
µg∙(106 x)-1] is optimal for permeabilization 
of endothelial cells, and the concentration in 
the incubation medium has to be adjusted 
according to the cell-mass concentration 
[32]. Respiration of isolated mitochondria 
remains unaltered after the addition of low 
concentrations of digitonin or saponin. In 
addition to mechanical cell disruption during 
homogenization of tissue, permeabilization 
agents may be applied to ensure 
permeabilization of all cells in tissue 
homogenates. 
 Suspensions of cells permeabilized in the 
respiration chamber and crude tissue 
homogenates contain all components of the 
cell at highly dilute concentrations. All 
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mitochondria are retained in chemically-
permeabilized mitochondrial preparations 
and crude tissue homogenates. In the 
preparation of isolated mitochondria, 
however, the mitochondria are separated 
from other cell fractions and purified by 
differential centrifugation, entailing the loss 
of mitochondria at typical recoveries ranging 
from 30 to 80 % of total mitochondrial 
content [71]. Using Percoll or sucrose 
density gradients to maximize the purity of 
isolated mitochondria may compromise the 
mitochondrial yield or structural and 
functional integrity. Therefore, 
mitochondrial isolation protocols need to be 
optimized according to each study. The term 
mitochondrial preparation neither includes 
living cells, nor submitochondrial particles 
and further fractionated mitochondrial 
components. 
 
2.3. Electron transfer pathways 
 
Mitochondrial electron transfer (ET) 
pathways are fuelled by diffusion and 
transport of substrates across the mtOM and 
mtIM. In addition, the mitochondrial 
electron transfer system ETS consists of the 
matrix-ETS and membrane-ETS (Figure 1b). 
Upstream sections of ET-pathways converge 
at the NADH-junction (N-junction). NADH is 
mainly generated in the TCA cycle and is 
oxidized by Complex I (CI), with further 
electron entry into the coenzyme Q-junction 
(Q-junction). Similarly, succinate is formed 
in the TCA cycle and oxidized by CII to 
fumarate. CII is part of both the TCA cycle 
and the ETS, and reduces FAD to FADH2 with 
further reduction of ubiquinone to ubiquinol 
downstream of the TCA cycle in the Q-
junction. Thus FADH2 is not a substrate but is 
the product of CII, in contrast to erroneous 
metabolic maps shown in many publications. 
β-oxidation of fatty acids FA supplies 
reducing equivalents via (1) FADH2 as the 
substrate of electron transferring 
flavoprotein complex CETF; (2) acetyl-CoA 
generated by chain shortening; and (3) 
NADH generated via 3-hydroxyacyl-CoA 
dehydrogenases. The ATP yield depends on 
whether acetyl-CoA enters the TCA cycle, or 
is for example used in ketogenesis. 
Table 1. Coupling states and rates, and residual oxygen consumption in mitochondrial 
preparations. Respiration- and phosphorylation-flux, JkO2 and JP», are rates, characteristic of a 
state in conjunction with the protonmotive force pmF. Coupling states are established at 
kinetically-saturating concentrations of oxidizable ‘fuel’ substrates and O2. 
State Rate  JkO2  JP» pmF Inducing 
factors 
Limiting factors 
LEAK L low, cation 
leak-
dependent 
respiration  
0 max. back-flux of 
cations including 
proton leak, 
proton slip  
JP» = 0: (1) without ADP, 
L(n); (2) max. ATP/ADP 
ratio, L(T); or (3) inhibition 
of the phosphorylation-
pathway, L(Omy) 
OXPHOS P high, ADP-
stimulated 
respiration, 
OXPHOS-
capacity 
max. high  kinetically-
saturating [ADP] 
and [Pi] 
JP» by phosphorylation-
pathway capacity; or JkO2 by 
ET-capacity 
ET E max., 
noncoupled 
respiration,  
ET-capacity 
0 low  optimal external 
uncoupler 
concentration for 
max. JO2,E 
JkO2 by ET-capacity 
ROX Rox min., residual 
O2 
consumption 
0 0 JO2,Rox in non-ET-
pathway 
oxidation 
reactions 
inhibition of all ET-
pathways; or absence of fuel 
substrates 
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 Selected mitochondrial catabolic 
pathways of electron transfer from the 
oxidation of fuel substrates to the reduction 
of O2 are stimulated by addition of fuel 
substrates to the mitochondrial respiration 
medium after depletion of endogenous 
substrates (Figure 1b). Substrate 
combinations and specific inhibitors of ET-
pathway enzymes are used to obtain defined 
pathway control states in mitochondrial 
preparations [54]. 
 
2.4. Respiratory coupling control 
 
2.4.1. Coupling: Coupling of electron transfer 
(ET) to phosphorylation of ADP to ATP is 
mediated by vectorial translocation of protons 
across the mtIM. Proton pumps generate or 
utilize the electrochemical pmF (Figure 1). 
The pmF is the sum of two partial forces, the 
electric force (electric potential difference) and 
chemical force (proton chemical potential 
difference, related to ΔpH [92; 93]). The 
catabolic flux of scalar reactions is 
collectively measured as O2 flux JkO2.  
 Thus mitochondria are elementary 
components of energy transformation. 
Energy is a conserved quantity and cannot be 
lost or produced in any internal process 
(First Law of Thermodynamics). Open and 
closed systems can gain or lose energy only 
by external fluxes—by exchange with the 
environment. Therefore, energy can neither 
be produced by mitochondria, nor is there 
any internal process without energy 
conservation. Exergy or Gibbs energy (‘free 
energy’) is the part of energy that can 
potentially be transformed into work under 
conditions of constant temperature and 
pressure. Coupling is the interaction of an 
exergonic process (spontaneous, negative 
exergy change) with an endergonic process 
(positive exergy change) in energy 
transformations which conserve part of the 
exergy change. Exergy is not completely 
conserved, however, except at the limit of 
100 % efficiency of energy transformation in 
a coupled process [49]. The exergy or Gibbs 
energy change that is not conserved by 
coupling is irreversibly dissipated, and is 
accounted for as the entropy change of the 
surroundings and the system, multiplied by 
the absolute temperature of the irreversible 
process [50]. 
 Pathway control states PCS and coupling 
control states CCS are  complementary, since 
mitochondrial preparations depend on (1) 
an exogenous supply of pathway-specific 
fuel substrates and oxygen, and (2) 
exogenous control of phosphorylation 
(Figure 1). 
 
2.4.2. Phosphorylation P» and P»/O2 
ratio: Phosphorylation in the context of 
OXPHOS is defined as phosphorylation of 
ADP by Pi to form ATP. On the other hand, the 
term phosphorylation is used generally in 
many contexts, e.g., protein phosphorylation. 
This provides the argument for introducing a 
symbol more discriminating and specific 
than P as used in the P/O ratio (phosphate to 
atomic oxygen ratio), where P indicates 
phosphorylation of ADP to ATP or GDP to 
GTP (Figure 1): The symbol P» indicates the 
endergonic (uphill) direction of 
phosphorylation ADP→ATP, and likewise P« 
the corresponding exergonic (downhill) 
hydrolysis ATP→ADP. P» refers mainly to 
electrontransfer phosphorylation but may 
also involve substrate-level phosphorylation 
as part of the TCA cycle (succinyl-CoA ligase, 
phosphoglycerate kinase) and 
phosphorylation of ADP catalyzed by 
pyruvate kinase, and of GDP phosphorylated 
by phosphoenolpyruvate carboxykinase. 
Transphosphorylation is performed by 
adenylate kinase, creatine kinase (mtCK), 
hexokinase and nucleoside diphosphate 
kinase. In isolated mammalian mitochondria, 
ATP production catalyzed by adenylate 
kinase (2 ADP ↔ ATP + AMP) proceeds 
without fuel substrates in the presence of 
ADP (Komlódi and Tretter 2017). Kinase 
cycles are involved in intracellular energy 
transfer and signal transduction for 
regulation of energy flux. The P»/O2 ratio 
(P»/4 e-) is two times the ‘P/O’ ratio (P»/2 
e-). P»/O2 is a generalized symbol, not 
specific for reporting Pi consumption (Pi/O2 
flux ratio), ADP depletion (ADP/O2 flux 
ratio), or ATP production (ATP/O2 flux 
ratio). The mechanistic P»/O2 ratio—or 
P»/O2 stoichiometry—is calculated from the 
proton–to–O2 and proton–to–
phosphorylation coupling stoichiometries 
(Figure 1c): 
 
 P»/O2  =   
Hpos
+ /O2
Hneg
+ /P»
 (1) 
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The H+pos/O2 coupling stoichiometry 
(referring to the full four electron reduction 
of O2) depends on the relative involvement of 
the three coupling sites (respiratory 
Complexes CI, CIII and CIV) in the catabolic 
ET-pathway from reduced fuel substrates 
(electron donors) to the reduction of O2 
(electron acceptor). This varies with a 
bypass of: (1) CI by single or multiple 
electron input into the Q-junction; and (2) 
CIV by involvement of alternative oxidases, 
AOX. AOX are expressed in all plants, some 
fungi, many protists, and several animal 
phyla, but are not expressed in vertebrate 
mitochondria [86]. 
 The H+pos/O2 coupling stoichiometry 
equals 12 in the ET-pathways involving CIII 
and CIV as proton pumps, increasing to 20 
for the NADH-pathway through CI (Figure 
1b). A general consensus on H+pos/O2 
stoichiometries, however, remains to be 
reached [59; 122; 141]. The H+neg/P» 
coupling stoichiometry (3.7; Figure 1b) is 
the sum of 2.7 H+neg required by the F1FO-
ATPase of vertebrate and most invertebrate 
species [138] and the proton balance in the 
translocation of ADP, ATP and Pi (Figure 1c). 
Taken together, the mechanistic P»/O2 ratio 
is calculated at 5.4 and 3.3 for the N- and S-
pathway, respectively (Eq. 1). The 
corresponding classical P»/O ratios 
(referring to the 2 electron reduction of 0.5 
O2) are 2.7 and 1.6 [138], in agreement with 
the measured P»/O ratio for succinate of 
1.58 ± 0.02 [57]. 
 
2.4.3. Uncoupling: The effective P»/O2 flux 
ratio (YP»/O2 = JP»/JkO2) is diminished relative 
to the mechanistic P»/O2 ratio by intrinsic 
and extrinsic uncoupling or dyscoupling 
(Figure 3). This is distinct from switching 
between mitochondrial pathways that 
involve fewer than three proton pumps 
(‘coupling sites’: Complexes CI, CIII and CIV), 
bypassing CI through multiple electron 
entries into the Q-junction, or bypassing CIII 
and CIV through AOX (Figure 1b). 
Reprogramming of mitochondrial pathways 
leading to different types of substrates being 
oxidized may be considered as a switch of 
gears (changing the stoichiometry by 
altering the substrate that is oxidized) rather 
than uncoupling (loosening the tightness of 
coupling relative to a fixed stoichiometry). In 
addition, YP»/O2 depends on several 
experimental conditions of flux control, 
increasing as a hyperbolic function of [ADP] 
to a maximum value [51]. Uncoupling of 
mitochondrial respiration is a general term 
comprising diverse mechanisms (Figure 3): 
 
1.  Proton leak across the mtIM from the 
positive to the negative compartment (H+ 
leak-uncoupled); 
2.  Cycling of other cations, strongly 
stimulated by mtPT; comparable to the 
use of protonophores, cation cycling is 
experimentally induced by valinomycin in 
the presence of K+; 
3.  Decoupling by proton slip in the redox 
proton pumps (CI, CIII and CIV) when 
protons are effectively not pumped in the 
ETS, or are not driving phosphorylation 
(F1FO-ATPase); 
4.  Loss of vesicular (compartmental) 
integrity when electron transfer is 
acoupled; 
5.  Electron leak in the loosely coupled 
univalent reduction of O2 to superoxide 
(O2•­; superoxide anion radical). 
 
 Differences of terms—uncoupled vs. 
noncoupled—are easily overlooked, 
although they relate to different meanings of 
uncoupling (Table 2 and Figure 3). 
 
2.5. Coupling states and respiratory rates 
 
To extend the classical nomenclature on 
mitochondrial respiratory states (Section 
2.6) by a concept-driven terminology that 
explicitly incorporates information on the 
meaning of respiratory states, the 
terminology must be general and not 
restricted to any particular experimental 
protocol or mitochondrial preparation [53]. 
Diagnostically meaningful and reproducible 
conditions are defined for measuring 
mitochondrial function and respiratory 
capacities of core energy metabolism. 
Standard respiratory coupling control states 
are obtained while maintaining a defined ET-
pathway state with constant fuel substrates 
and inhibitors of specific branches of the ET-
pathway. Concept-driven nomenclature 
aims at mapping the meaning and concept 
behind the words and acronyms onto the 
forms of words and acronyms [91]. The focus 
of concept-driven nomenclature is primarily 
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the conceptual why, along with clarification 
of the experimental how (Table 1). 
 
LEAK: The contribution of intrinsically 
uncoupled O2 consumption is studied by 
preventing the stimulation of 
phosphorylation either in the absence of 
ADP or by inhibition of the 
phosphorylation-pathway. The 
corresponding states are collectively 
classified as LEAK-states when O2 
consumption compensates mainly for ion 
leaks, including the proton leak. 
OXPHOS: The ET- and phosphorylation-
pathways comprise coupled segments of 
the OXPHOS-system and provide 
reference values of respiratory capacities. 
The OXPHOS-capacity is measured at 
kinetically-saturating concentrations of 
ADP, Pi, fuel substrates and O2. 
ET: Compared to OXPHOS-capacity, the 
oxidative ET-capacity reveals the 
limitation of OXPHOS-capacity mediated 
by the phosphorylation-pathway. By 
application of external uncouplers, ET-
capacity is measured as noncoupled 
respiration. The three coupling states, 
LEAK, OXPHOS, and ET are shown 
schematically with the corresponding 
respiratory rates, abbreviated as L, P, and 
E, respectively (Figure 2). We distinguish 
between metabolic pathways and 
metabolic states with the corresponding 
metabolic rates; for example: ET-
pathways, ET-states, and ET-capacities E, 
respectively (Table 1). The protonmotive 
force pmF is maximum in the LEAK-state 
of coupled mitochondria, driven by LEAK-
respiration at a minimum back-flux of 
cations to the matrix side, high in the 
OXPHOS-state when it drives 
phosphorylation, and very low in the ET-
state when uncouplers short-circuit the 
proton cycle (Table 1). 
Figure 3. Mechanisms of respiratory uncoupling 
An intact mitochondrial inner membrane, mtIM, is required for vectorial, compartmental 
coupling. Inducible uncoupling, e.g., by activation of UCP1, increases LEAK-respiration; 
experimentally noncoupled respiration provides an estimate of ET-capacity obtained by 
titration of protonophores stimulating respiration to maximum O2 flux. H+ leak-uncoupled, 
decoupled, and loosely coupled respiration are components of intrinsic uncoupling (Table 2). 
Pathological dysfunction may affect all types of uncoupling, including permeability transition 
mtPT, causing intrinsically dyscoupled respiration. Similarly, toxicological and environmental 
stress factors can cause extrinsically dyscoupled respiration. ‘Acoupled’ respiration is the 
consequence of structural disruption with catalytic activity of non-compartmental 
mitochondrial fragments. Reduced fuel substrates, red; oxidized products, ox. 
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2.5.1. LEAK-state (Figure 4a): The LEAK-
state is defined as a state of mitochondrial 
respiration when O2 flux mainly 
compensates for ion leaks in the absence 
of ATP synthesis, at kinetically-saturating 
concentrations of O2 and respiratory fuel 
substrates. LEAK-respiration is measured 
to obtain an estimate of intrinsic 
uncoupling without addition of an 
experimental uncoupler: (1) in the 
absence of adenylates, i.e., AMP, ADP and 
ATP; (2) after depletion of ADP at a 
maximum ATP/ADP ratio; or (3) after 
inhibition of the phosphorylation-
pathway by inhibitors of F1FO-ATPase 
(oligomycin), or adenine nucleotide 
translocase (carboxyatractyloside). 
Adjustment of the nominal concentration 
of these inhibitors to the concentration of 
biological sample applied can minimize or 
avoid inhibitory side-effects exerted on 
ET-capacity or even some dyscoupling. 
The chelator EGTA is added to mt-
respiration media to bind free Ca2+, thus 
limiting cation cycling. The LEAK-rate is a 
function of respiratory state, hence it 
depends on (1) the barrier function of the 
mtIM (‘leakiness’), (2) the 
electrochemical potential differences and 
concentration differences across the 
mtIM, and (3) the H+/O2 ratio of the ET-
pathway (Figure 1b). 
 
• Proton leak and uncoupled 
respiration: The intrinsic proton leak is 
Table 2. Terms on respiratory coupling and uncoupling 
 
Term JkO2 P»/O2 Notes 
    
uncoupled L 0 non-phosphorylating LEAK-respiration (Fig. 2) 
proton leak- 
uncoupled 
 0 component of L, H+ diffusion across the mtIM (Fig. 
2b-d) 
inducibly 
uncoupled 
 0 by UCP1 or cation (e.g., Ca2+) cycling, strongly 
stimulated by permeability transition mtPT; 
experimentally induced by valinomycin in the 
presence of K+ 
decoupled   0 component of L, proton slip when protons are 
effectively not pumped in the redox proton pumps 
CI, CIII and CIV or are not driving phosphorylation 
(F1FO-ATPase [16]) (Fig. 2b-d) 
loosely 
coupled 
 0 component of L, lower coupling due to superoxide 
formation and bypass of proton pumps by electron 
leak with univalent reduction of O2 to superoxide 
(O2•–; superoxide anion radical) 
dyscoupled   0 mitochondrial dysfunction due to pathologically, 
toxicologically, environmentally increased 
uncoupling 
noncoupled  E 0 ET-capacity, non-phosphorylating respiration 
stimulated to maximum flux at optimum exogenous 
protonophore concentration (Fig. 2d) 
well-coupled P high  OXPHOS-capacity, phosphorylating respiration 
with an intrinsic LEAK component (Fig. 2c) 
fully coupled P – L max. OXPHOS-capacity corrected for LEAK-respiration 
(Fig. 2a) 
acoupled   0 electron transfer in mitochondrial fragments 
without vectorial proton translocation upon loss of 
vesicular (compartmental) integrity 
 
in
tr
in
si
c,
 n
o
 p
ro
to
n
o
p
h
o
re
 a
d
d
ed
 
 
 
 
  Consortium Communication 
16 of 44 Gnaiger E et al ― MitoEAGLE Task Group (2020) Bioenerg Commun 2020.1 
 
the uncoupled leak current of protons in 
which protons diffuse across the mtIM in 
the dissipative direction of the downhill 
pmF without coupling to phosphorylation 
(Figure 4a). The proton leak flux depends 
non-linearly on the electric membrane 
potential difference [31; 45], which is a 
temperature-dependent property of the 
mtIM and may be enhanced due to 
possible contamination by free fatty acids. 
Inducible uncoupling mediated by 
uncoupling protein 1 (UCP1) is 
physiologically controlled, e.g., in brown 
adipose tissue. UCP1 is a member of the 
mitochondrial carrier family that is 
involved in the translocation of protons 
across the mtIM [64]. Consequently, this 
short-circuit lowers the pmF and 
stimulates electron transfer, respiration, 
and heat dissipation in the absence of 
phosphorylation of ADP. 
• Cation cycling: There can be other cation 
contributors to leak current including 
Ca2+ and probably magnesium. Ca2+ influx 
is balanced by mitochondrial Na+/Ca2+ or 
H+/Ca2+ exchange, which is balanced by 
Na+/H+ or K+/H+ exchanges. This is 
another effective uncoupling mechanism 
different from proton leak (Table 2). 
• Proton slip and decoupled respiration: 
Proton slip is the decoupled process in 
which protons are only partially 
translocated by a redox proton pump of 
the ET-pathways and slip back to the 
original vesicular compartment. The 
proton leak is the dominant contributor 
to the overall leak current in mammalian 
mitochondria incubated under 
physiological conditions at 37 °C, whereas 
proton slip increases at lower 
experimental temperature [16]. Proton 
slip can also happen in association with 
the F1FO-ATPase, in which the proton slips 
downhill across the pump to the matrix 
without contributing to ATP synthesis. In 
each case, proton slip is a property of the 
proton pump and increases with the 
pump turnover rate. 
• Electron leak and loosely coupled 
respiration: Superoxide production by 
the ETS leads to a bypass of redox proton 
pumps and correspondingly lower P»/O2 
ratio. This depends on the actual site of 
electron leak and the scavenging of 
superoxide by cytochrome c, whereby 
electrons may re-enter the ETS with 
proton translocation by CIV. 
• Dyscoupled respiration: Mitochondrial 
injuries may lead to dyscoupling as a 
pathological or toxicological cause of 
uncoupled respiration. Dyscoupling may 
involve any type of uncoupling 
mechanism, e.g., opening the mtPT pore. 
Dyscoupled respiration is distinguished 
from experimentally induced noncoupled 
respiration in the ET-state (Table 2). 
• Protonophore titration and non-
coupled respiration: Protonophores are 
uncouplers which are titrated to obtain 
maximum noncoupled respiration as a 
measure of ET-capacity. 
• Loss of compartmental integrity and 
acoupled respiration: Electron transfer 
and catabolic O2 flux proceed without 
compartmental proton translocation in 
disrupted mitochondrial fragments. Such 
fragments are an artefact of 
mitochondrial isolation, and may not fully 
fuse to re-establish structurally intact 
mitochondria. Loss of mtIM integrity, 
therefore, is the cause of acoupled 
respiration, which is a nonvectorial 
dissipative process without control by the 
pmF. 
 
2.5.2. OXPHOS-state (Figure 4b): The 
OXPHOS-state is defined as the respiratory 
state with kinetically-saturating 
concentrations of ADP and Pi 
(phosphorylation substrates), respiratory 
fuel substrates and O2, in the absence of 
exogenous uncoupler, to estimate the 
maximal respiratory capacity in the 
OXPHOS-state for any given ET-pathway 
state. Respiratory capacities at kinetically-
saturating substrate concentrations provide 
reference values or upper limits of 
performance, aiming at the generation of 
data sets for comparative purposes. 
Physiological activities and effects of 
substrate kinetics can be evaluated relative 
to the OXPHOS-capacity. 
 As discussed previously, 0.2 mM ADP 
does not kinetically-saturate flux in isolated 
mitochondria [51; 107]; greater [ADP] is 
required, particularly in permeabilized 
muscle fibers and cardiomyocytes, to 
overcome limitations by intracellular 
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diffusion and by the reduced conductance of 
the mtOM [61; 63; 127], either through  
interaction with tubulin [118] or other 
intracellular structures [5]. In addition, 
kinetically-saturating ADP concentrations 
need to be evaluated under different 
experimental conditions such as 
temperature [78] and with different animal 
models [7]. In permeabilized muscle fiber 
bundles of high respiratory capacity, the 
apparent Km for ADP increases up to 0.5 mM 
[120], consistent with experimental 
evidence that >90 % kinetic saturation is 
reached only at >5 mM ADP [104]. Similar 
ADP concentrations are also required for 
accurate determination of OXPHOS-capacity 
in human clinical cancer samples and 
permeabilized cells [67; 68]. 2.5 to 5 mM 
ADP is sufficient to obtain the actual 
OXPHOS-capacity in many types of 
permeabilized tissue and cell preparations, 
but experimental validation is required in 
each specific case. 
 
2.5.3. Electron transfer-state (Figure 4c): 
O2 flux determined in the ET-state yields an 
estimate of ET-capacity. The ET-state is 
defined as the noncoupled state with 
optimum exogenous uncoupler 
concentration for maximum O2 flux at 
kinetically-saturating concentrations of 
respiratory fuel substrates and O2. 
Uncouplers are weak lipid-soluble acids 
which function as protonophores. These 
disrupt the barrier function of the mtIM and 
thus short-circuit the protonmotive system, 
functioning like a clutch in a mechanical 
system. As a consequence of the nearly 
collapsed protonmotive force, the driving 
force is insufficient for phosphorylation, and 
JP» = 0. The most frequently used uncouplers 
are carbonyl cyanide m-chloro phenyl 
hydrazone (CCCP), carbonyl cyanide p-
trifluoromethoxyphenylhydrazone (FCCP), 
or dinitrophenol (DNP). Stepwise titrations 
of uncouplers stimulate respiration up to or 
above the level of O2 consumption rates in 
the OXPHOS-state; respiration is inhibited, 
however, above optimum uncoupler 
concentrations [93]. Data obtained with a 
single dose of uncoupler must be evaluated 
with caution, particularly when a fixed 
Figure 4. Respiratory coupling states 
 (a) LEAK-state and rate L: Oxidation 
only, since phosphorylation is arrested, JP» 
= 0, and catabolic O2 flux JkO2,L is controlled 
mainly by the proton leak and slip JmH+neg 
(motive, subscript m), at maximum 
protonmotive force (Figure 2). ATP may 
be hydrolyzed by ATPases, JP«; then 
phosphorylation must be blocked. 
 (b) OXPHOS-state and rate P: 
Oxidation coupled to phosphorylation JP», 
which is stimulated by kinetically-
saturating [ADP] and [Pi], supported by a 
high protonmotive force maintained by 
pumping of protons to the positive 
compartment, JmH+pos. O2 flux JkO2,P is well-
coupled at a P»/O2 flux ratio of JP»,P∙JO2,P-1. 
Extramitochondrial ATPases may recycle 
ATP to ADP, JP«.  
 (c) ET-state and rate E: Oxidation only, 
since phosphorylation is zero, JP» = 0, at 
optimum exogenous uncoupler 
concentration when noncoupled 
respiration JkO2,E is maximum. The F1FO-
ATPase may hydrolyze extramitochondrial 
ATP. Modified from [54]. 
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uncoupler concentration is used in studies 
exploring a treatment or disease that may 
alter the mitochondrial content or 
mitochondrial sensitivity to inhibition by 
uncouplers. There is a need for new 
protonophoric uncouplers that drive 
maximal respiration across a broad dosing 
range and do not inhibit respiration at high 
concentrations [66]. The effect on ET-
capacity of the reversed function of F1FO-
ATPase (JP«; Figure 4c) can be evaluated in 
the presence and absence of 
extramitochondrial ATP. 
 
2.5.4. ROX state: The state of residual O2 
consumption ROX, is not a coupling state, but 
is relevant to assess respiratory function 
(Overview). The rate of residual oxygen 
consumption Rox is defined as O2 
consumption due to oxidative reactions 
measured after inhibition of ET with 
antimycin A alone, or in combination with 
rotenone and malonic acid. Cyanide and 
azide not only inhibit CIV, but also catalase 
and several peroxidases involved in Rox, 
whereas AOX is not inhibited (Figure 1b). 
High concentrations of antimycin A, but not 
rotenone or cyanide, inhibit peroxisomal 
acyl-CoA oxidase and D-amino acid oxidase 
[134]. Rox represents a baseline used to 
correct respiration measured in defined 
coupling control states. Rox-corrected L, P 
and E are not only lower than total fluxes, but 
also change the flux control ratios L/P and 
L/E. Rox is not necessarily equivalent to non-
mitochondrial reduction of O2. This is 
important when considering O2-consuming 
reactions in mitochondria that are not 
related to ET—such as O2 consumption in 
reactions catalyzed by monoamine oxidases 
(type A and B), monooxygenases 
(cytochrome P450 monooxygenases), 
dioxygenases (trimethyllysine dioxygenase), 
and several hydoxylases. Isolated 
mitochondrial fractions, especially those 
obtained from liver, may be contaminated by 
peroxisomes, as shown by transmission 
electron microscopy. This fact makes the 
exact determination of mitochondrial O2 
consumption and mitochondria-associated 
generation of reactive oxygen species 
complicated [124; 129] (Figure 1). The 
variability of ROX-linked O2 consumption 
needs to be studied in relation to non-ET 
enzyme activities, availability of specific 
substrates, O2 concentration, and electron 
leakage leading to the formation of reactive 
oxygen species. 
 
2.5.5. Quantitative relations: E may exceed 
or be equal to P. E > P is observed in many 
types of mitochondria, varying between 
species, tissues and cell types [53]. E-P is the 
ET-excess capacity pushing the 
phosphorylation-flux to the limit of its 
capacity for utilizing the pmF (Figure 2). In 
addition, the magnitude of E-P depends on 
the tightness of respiratory coupling or 
degree of uncoupling, since an increase of L 
causes P to increase towards the limit of E 
[79]. The ET-excess capacity E-P, therefore, 
provides a sensitive diagnostic indicator of 
specific injuries of the phosphorylation-
pathway, under conditions when E remains 
constant but P declines relative to controls. 
Substrate cocktails supporting simultaneous 
convergent electron transfer to the Q-
junction for reconstitution of TCA cycle 
function establish pathway control states 
with high ET-capacity, and consequently 
increase the sensitivity of the E-P assay. 
 E cannot theoretically be lower than P. 
E<P must be discounted as an artefact, which 
may be caused experimentally by: (1) loss of 
oxidative capacity during the time course of 
the respirometric assay, since E is measured 
subsequently to P; (2) using insufficient 
uncoupler concentrations; (3) using high 
uncoupler concentrations which inhibit ET 
[52]; (4) high oligomycin concentrations 
applied for measurement of L before 
titrations of uncoupler, when oligomycin 
exerts an inhibitory effect on E. On the other 
hand, the apparent ET-excess capacity is 
overestimated if kinetically non-saturating 
[ADP] or [Pi] are used. See State 3 in the next 
section. 
 The net OXPHOS-capacity is calculated by 
subtracting L from P, which requires a 
cautionary note (Figure 2). The net P»/O2 
equals P»/(P-L), wherein the dissipative 
LEAK component in the OXPHOS-state may 
be overestimated. This can be avoided by 
measuring LEAK-respiration in a state when 
the pmF is adjusted to its slightly lower value 
in the OXPHOS-state by titration of an ET-
inhibitor [31]. Any turnover-dependent 
components of proton leak and slip, 
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however, are underestimated under these 
conditions [46]. In general, it is 
inappropriate to use the term ATP 
production or ATP turnover for the difference 
of O2 fluxes measured in the OXPHOS- and 
LEAK-states. P-L is the upper limit of 
OXPHOS-capacity that is freely available for 
ATP production (corrected for LEAK-
respiration) and is fully coupled to 
phosphorylation with a maximum 
mechanistic stoichiometry (Figure 2). 
 LEAK-respiration and OXPHOS-capacity 
depend on (1) the tightness of coupling 
under the influence of the respiratory 
uncoupling mechanisms (Figure 3), and (2) 
the coupling stoichiometry, which varies as a 
function of the substrate type undergoing 
oxidation in ET-pathways with either two or 
three coupling sites (Figure 1b). When 
substrate cocktails are used supporting the 
convergent NADH- and succinate-pathways 
simultaneously, the relative contribution of 
ET-pathways with three or two coupling 
sites cannot be controlled experimentally, is 
difficult to determine, and may shift in 
transitions between LEAK-, OXPHOS- and 
ET-states [54]. Under these experimental 
conditions, we cannot separate the tightness 
of coupling versus coupling stoichiometry as 
the mechanisms of respiratory control in a 
shift of L/P ratios. The tightness of coupling 
and fully coupled O2 flux (P-L; Table 2), 
therefore, are obtained from measurements 
of coupling control of LEAK-respiration, 
OXPHOS- and ET-capacities in well-defined 
pathway states, using either pyruvate and 
malate as substrates or the classical 
succinate and rotenone substrate-inhibitor 
combination (Figure 1b). 
 
2.5.6. The steady-state: Mitochondria 
represent a thermodynamically open system 
in non-equilibrium states of biochemical 
energy transformation. State variables 
(redox states; pmF) and metabolic rates 
(fluxes) are measured in defined 
mitochondrial respiratory states. Steady-
states can be obtained only in open systems, 
in which changes by internal 
transformations, e.g., O2 consumption, are 
instantaneously compensated for by 
external fluxes across the system boundary, 
e.g., O2 supply, thus preventing a change of O2 
concentration in the system [50]. 
Mitochondrial respiratory states monitored 
in closed systems satisfy the criteria of 
pseudo-steady states for limited periods of 
time, when changes in the system 
(concentrations of O2, fuel substrates, ADP, 
Pi, H+) do not exert significant effects on 
metabolic fluxes (respiration, 
phosphorylation). Such pseudo-steady states 
require respiratory media with sufficient 
buffering capacity and substrates 
maintained at kinetically-saturating 
concentrations, and thus depend on the 
kinetics of the processes under investigation. 
 
2.6. Classical terminology for isolated 
mitochondria 
 
‘When a code is familiar enough, it ceases 
appearing like a code; one forgets that 
there is a decoding mechanism. The 
message is identical with its meaning’ 
(Hofstadter 1979) [60]. 
 
Chance and Williams [20; 21] introduced five 
classical mitochondrial respiratory states 
and cytochrome redox states. Table 3 shows 
a protocol with isolated mitochondria in a 
closed respirometric chamber, defining a 
sequence of respiratory states. States and 
rates are not distinguished in this 
nomenclature. 
Table 3. Metabolic states of mitochondria (Chance and 
Williams, 1956; Table V). 
 
State 
 
[O2] 
ADP 
level 
Substrate 
  level 
Respiration 
  rate 
Rate-limiting 
  substance 
1 >0 low   low   slow   ADP 
2 >0 high   ~0   slow   substrate 
3 >0 high   high   fast   respiratory chain 
4 >0 low   high   slow   ADP 
5 0 high   high   0   oxygen 
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2.6.1. State 1 is obtained after addition of 
isolated mitochondria to air-saturated 
isoosmotic/isotonic respiration medium 
containing Pi, but no mitochondrial fuel 
substrates and no adenylates. 
 
2.6.2. State 2 is induced by addition of a 
‘high’ concentration of ADP (typically 100 to 
300 µM), which stimulates respiration 
transiently on the basis of endogenous fuel 
substrates and phosphorylates only a small 
portion of the added ADP. State 2 is then 
obtained at a low respiratory activity limited 
by exhausted endogenous fuel substrate 
availability (Table 3). If addition of specific 
inhibitors of respiratory complexes such as 
rotenone does not cause a further decline of 
O2 flux, State 2 is equivalent to the ROX state 
(Table 1). Undefined endogenous fuel 
substrates are a confounding factor of 
pathway control, contributing to the effect of 
subsequently added external substrates and 
inhibitors. In an alternative sequence of 
titration steps, the second state (not 
introduced as State 2) is induced by addition 
of fuel substrate without ADP or ATP [20, 
39]. In contrast to the original State 2 defined 
in Table 1 as a ROX state, the alternative 
‘State 2’ is a LEAK-state, L(n). Some 
researchers have called this condition as 
‘pseudostate 4’. 
 
2.6.3. State 3 is the state stimulated by 
addition of fuel substrates while the ADP 
concentration in the original State 2 is still 
high (Table 3) and supports coupled energy 
transformation. 'High ADP' is a 
concentration of ADP specifically selected to 
allow the measurement of State 3 to State 4 
transitions of isolated mitochondria in a 
closed respirometric chamber. Repeated 
ADP titration re-establishes State 3 at ‘high 
ADP’. Starting at O2 concentrations near air-
saturation (193 or 238 µM O2 at 37 °C or 25 
°C and sea level at 1 atm or 101.32 kPa, and 
an O2 solubility of respiration medium at 
0.92 times that of pure water [44]), the total 
ADP concentration added must be low 
enough (typically 100 to 300 µM) to allow 
phosphorylation to ATP at a coupled O2 flux 
that does not lead to O2 depletion during the 
transition to State 4. In contrast, kinetically-
saturating ADP concentrations usually are 
10-fold higher than 'high ADP', e.g., 2.5 mM in 
isolated mitochondria. The abbreviation 
‘State 3u’ is occasionally used in 
bioenergetics, to indicate the state of 
respiration after titration of an uncoupler, 
without sufficient emphasis on the 
fundamental difference between OXPHOS-
capacity (well-coupled with an endogenous 
uncoupled component) and ET-capacity 
(noncoupled). 
 
2.6.4. State 4 is a LEAK-state that is obtained 
only if the mitochondrial preparation is 
intact and well-coupled. Depletion of ADP by 
phosphorylation to ATP causes a decline of 
O2 flux in the transition from State 3 to State 
4. Under the conditions of State 4, a 
maximum protonmotive force and high 
ATP/ADP ratio are maintained. The gradual 
decline of YP»/O2 towards diminishing [ADP] 
at State 4 must be taken into account for 
calculation of P»/O2 ratios [51]. State 4 
respiration L(T) (Table 1), reflects intrinsic 
proton leak and ATP hydrolysis activity. O2 
flux in State 4 is an overestimation of LEAK-
respiration if any contaminating ATP 
hydrolysis activity recycles some ATP to 
ADP, JP«, which stimulates respiration 
coupled to phosphorylation, JP» > 0. Some 
degree of mechanical disruption and loss of 
mitochondrial integrity allows the exposed 
mitochondrial F1FO-ATPases to hydrolyze 
the ATP synthesized by the fraction of 
coupled mitochondria. This can be tested by 
inhibition of the phosphorylation-pathway 
using oligomycin, ensuring that JP» = 0 (State 
4o). On the other hand, the State 4 
respiration reached after exhaustion of 
added ADP is a more physiological condition, 
i.e., presence of ATP, ADP and even AMP. 
Sequential ADP titrations re-establish State 
3, followed by State 3 to State 4 transitions 
while sufficient O2 is available. Anoxia may 
be reached, however, before exhaustion of 
ADP (State 5). 
 
2.6.5. State 5 ‘may be obtained by antimycin 
A treatment or by anaerobiosis’ [20]. These 
definitions give State 5 two different 
meanings: ROX or anoxia. Anoxia is obtained 
after exhaustion of O2 in a closed 
respirometric chamber. Diffusion of O2 from 
the surroundings into the aqueous solution 
may be a confounding factor preventing 
complete anoxia [51]. 
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 In Table 3, only States 3 and 4 are 
coupling control states, with the restriction 
that rates in State 3 may be limited 
kinetically by non-saturating ADP 
concentrations. 
 
2.7. Control and regulation 
 
The terms metabolic control and regulation 
are frequently used synonymously, but are 
distinguished in metabolic control analysis: 
‘We could understand the regulation as the 
mechanism that occurs when a system 
maintains some variable constant over time, 
in spite of fluctuations in external conditions 
(homeostasis of the internal state). On the 
other hand, metabolic control is the power to 
change the state of the metabolism in 
response to an external signal’ [43]. 
Respiratory control may be induced by 
experimental control signals that exert an 
influence on: (1) ATP demand and ADP 
phosphorylation-rate; (2) fuel substrate 
composition, pathway competition; (3) 
available amounts of substrates and O2, e.g., 
starvation and hypoxia; (4) the 
protonmotive force, redox states, flux–force 
relationships, coupling and efficiency; (5) 
Ca2+ and other ions including H+; (6) 
inhibitors, e.g., nitric oxide or intermediary 
metabolites such as oxaloacetate; (7) 
signalling pathways and regulatory proteins, 
e.g., insulin resistance, transcription factor 
hypoxia inducible factor 1.  
 Mechanisms of respiratory control and 
regulation include adjustments of: (1) 
enzyme activities by allosteric mechanisms 
and phosphorylation; (2) enzyme content, 
concentrations of cofactors and conserved 
moieties such as adenylates, nicotinamide 
adenine dinucleotide [NAD+/NADH], 
coenzyme Q, cytochrome c; (3) metabolic 
channeling by supercomplexes; and (4) 
mitochondrial density (enzyme 
concentrations) and morphology 
(membrane area, cristae folding, fission and 
fusion). Mitochondria are targeted directly 
by hormones, e.g., progesterone and 
glucocorticoids, which affect their energy 
metabolism [48; 74; 96; 106; 128]. 
Evolutionary or acquired differences in the 
genetic and epigenetic basis of 
mitochondrial function (or dysfunction) 
between individuals; age; biological sex, and 
hormone concentrations; life style including 
exercise and nutrition; and environmental 
issues including thermal, atmospheric, toxic 
and pharmacological factors, exert an 
influence on all control mechanisms listed 
above. For reviews, see [10; 49; 53; 54; 97; 
103]. 
 Lack of control by a metabolic pathway, 
e.g., phosphorylation-pathway, means that 
there will be no response to a variable 
activating it, e.g., [ADP]. The reverse, 
however, is not true as the absence of a 
response to [ADP] does not exclude the 
phosphorylation-pathway from having some 
degree of control. The degree of control of a 
component of the OXPHOS-pathway on an 
output variable, such as O2 flux, will in 
general be different from the degree of 
control on other outputs, such as 
phosphorylation-flux or proton leak flux. 
Therefore, it is necessary to be specific as to 
which input and output are under 
consideration [43]. 
 Respiratory control refers to the ability of 
mitochondria to adjust O2 flux in response to 
external control signals by engaging various 
mechanisms of control and regulation. 
Respiratory control is monitored in a 
mitochondrial preparation under conditions 
defined as respiratory states, preferentially 
under near-physiological conditions of 
temperature, pH, and medium ionic 
composition, to generate data of higher 
biological relevance. When phosphorylation 
of ADP to ATP is stimulated or depressed, an 
increase or decrease is observed in electron 
transfer measured as O2 flux in respiratory 
coupling states of intact mitochondria 
(‘controlled states’ in the classical 
terminology of bioenergetics). Alternatively, 
coupling of electron transfer with 
phosphorylation is diminished by 
uncouplers. The corresponding coupling 
control state is characterized by a high 
respiratory rate without control by P» 
(noncoupled or ‘uncontrolled state’). 
 
3. What is a rate? 
 
‘Before stating the result of a measurement, it 
is essential that the quantity being presented 
is adequately described‘ [11]. The term rate is 
not adequately defined to be useful for 
reporting data. Normalization of rates leads 
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to a diversity of formats expressed in various 
units. The second [s] is the SI unit for the 
base quantity time. It is also the standard 
time-unit used in solution chemical kinetics. 
 The inconsistency of the meanings of rate 
becomes apparent when considering Galileo 
Galilei’s famous principle, that ‘bodies of 
different weight all fall at the same rate (have 
a constant acceleration)’ [26]. A rate may be 
an extensive quantity [24], which is a flow I, 
when expressed per single object (per 
elementary entity X [11]; cell, organism) or 
per instrumental chamber (system). ‘System’ 
is defined as the open or closed chamber of 
the measuring device including a sample s. 
Alternatively, a rate is a flux J, when 
expressed as a size-specific quantity [50] 
(Figure 5a; Box 2). Importantly, a rate can 
be a nondimensional flux control ratio FCR. 
 
• Extensive quantities: An extensive 
quantity increases proportionally with 
system size. For example, mass and 
volume are extensive quantities. Flow is 
an extensive quantity. The magnitude of 
an extensive quantity is completely 
additive for non-interacting subsystems. 
The magnitude of these quantities 
depends on the extent or size of the 
system [24].  
• Size-specific quantities: ‘The adjective 
specific before the name of an extensive 
quantity is often used to mean divided by 
mass’ [24]. The term specific, however, 
has different meanings in three particular 
contexts: (1) In the system-paradigm, (a) 
mass-specific flux is flow divided by mass 
of the system (the mass of everything 
contained in the instrumental chamber or 
reactor). (b) Rates are frequently 
expressed as volume-specific flux 
(volume of the instrumental chamber). A 
mass-specific or volume-specific quantity 
is independent of the extent of non-
interacting homogenous subsystems. (2) 
In the context of sample size, tissue-
specific quantities are related to the mass 
or volume of the sample in contrast to the 
mass or volume of the system (e.g., muscle 
mass-specific or cell volume-specific 
normalization; Figure 5). (3) An entirely 
different meaning of ‘specific’ is implied 
in the context of sample type, e.g., muscle-
specific compared to brain-specific 
properties. 
• Intensive quantities: In contrast to size-
specific properties, forces are intensive 
quantities defined as the change of an 
extensive quantity per advancement of an 
energy transformation [50]. 
• Formats: Mass ms can be measured on 
any sample s, but a number of objects NX 
and a molar amount nB can be defined in 
samples of countable objects. The molar 
format is preferred for metabolites 
including O2. As of 2019 May 20, the 
definition of the SI unit mole [mol] is 
based on a natural constant, namely 
Avogadro’s constant: one mole contains 
exactly 6.02214076∙1023 elementary 
entities, in contrast to the former 
definition in terms of the number of 
molaratoms in the mass of 0.012 kilogram 
of carbon 12 [11]. Metabolic O2 flow and 
flux are expressed in molar units [mol] in 
biochemistry, but as volume [L] in 
ergometry. When necessary, these 
formats can be distinguished as JnO2/m and 
JVO2/m, respectively, indicating the 
different formats of O2 in subscripts (n, V) 
with the symbols of the quantities in 
underlined italic font. In many cases it is 
more practical, however, to use simpler 
symbols and provide the required 
definitions in the text and explicitly 
written units (Table 4 and Figure 5). 
 
Box 2: Metabolic flows and fluxes: 
vectoral, vectorial, and scalar 
 
Flow is an extensive quantity (I; per system), 
distinguished from flux as a size-specific 
quantity (J; per system size). Flows Itr are 
defined for all transformations as extensive 
quantities. This is a generalization derived 
from electrical terms: Electric charge per 
unit time is electric flow or current, Iel = 
dQel∙dt-1 [A≡ C∙s-1]. When dividing Iel by size 
of the system (cross-sectional area of a 
‘wire’), we obtain flux as a size-specific 
quantity; this is the current density (surface-
density of flow) perpendicular to the 
direction of flux, Jel = Iel∙A-1 [A∙m-2] [24]. 
Fluxes with spatial geometric direction and 
magnitude are vectors. Vector and scalar 
fluxes are related to flows as Jtr = Itr∙A-1 
[mol∙s-1∙m-2] and Jtr = Itr∙V-1  [mol∙s-1∙m-3], 
expressing flux as an area-specific vector or 
volume-specific vectorial or scalar quantity, 
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respectively [50]. We use the meter–
kilogram–second–ampere (MKSA) 
International System of Units (SI) for general 
cases ([m], [kg], [s] and [A]), with decimal SI 
prefixes and [L ≡ dm3] for specific 
applications (Table 4). 
 We suggest defining: (1) vectoral fluxes, 
which are translocations as functions of 
gradients with direction in geometric space 
in continuous systems; (2) vectorial fluxes, 
which describe translocations in 
discontinuous systems and are restricted to 
information on compartmental differences 
(transmembrane proton flux); and (3) scalar 
fluxes, which are localized transformations 
without translocation, such as chemical 
reactions or reaction sequences in a 
homogenous system (catabolic O2 flux JkO2). 
 
 
4. Normalization of rate per sample 
 
The challenges of measuring mitochondrial 
respiratory rate are matched by those of 
normalization. Normalization is guided by 
physicochemical principles, methodological 
considerations, and conceptual strategies 
(Table 4). Normalization per sample 
concentration is routinely required to report 
respiratory data (Figure 5). 
 
4.1. Flow: per number of object 
 
4.1.1. Count concentration CX: The count 
concentration of objects X is CX. 'Count' is 
synonymous with 'number of elementary 
entities' [11]. In the case of animals, NX is the 
number of organisms with concentration CX 
= NX∙V-1 [x∙L-1]. Similarly, the number of cells 
per chamber volume is the cell 
concentration, where Nce is the number of 
cells in the chamber (Table 4). 
 
4.1.2. Flow per single object IO2/X: O2 flow 
per cell is calculated from volume-specific O2 
flux JV,O2 [nmol∙s-1∙L-1] (per V [L] of the 
instrumental chamber), divided by the  
Figure 5. Normalization of rate. 
 (a) Left (physiological normalization): 
Rate can be expressed as extensive  flow 
IO2/X, if the sample can be quantified as a 
count NX (X: cell, organism). Rate is a size-
specific flux, JO2/ms or JO2/Vs, when 
expressed per mass or volume of sample s 
in the chamber, ms or Vs. Normalization 
per mitochondrial elementary marker 
mtE relies on determination of mtE 
expressed in a mt-elementary unit [mtEU]. 
A reference rate can be defined as a 
internal functional mtE, to obtain 
nondimensional flux control ratios that 
are independent of sample quantification 
or chamber volume. Right 
(methodological normalization): Flow in 
instrumental chamber IO2, or flux per 
chamber volume JV,O2.  
 (b) O2 flow per cell IO2/ce and CS activity 
as mtE: IO2/ce is the product of mt-specific 
flux JO2/CS, mt-density DCS=CS∙ms-1, and 
mass per cell MNce. Then performance is 
either the product of mass-specific flux 
JO2/mce [mol∙s-1∙kg-1] and size (mass per cell 
MNce [kg∙x-1]), or the product of 
mitochondrial function (mt-specific flux 
JO2/CS) and structure (CS per cell CSNce). 
Modified from [54]. See also Tab. 4. 
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   Table 4. Sample concentrations and normalization of flux. SI refers to ref. [11]. 
 
Expression Symbol Definition Unit    Notes 
Sample s sample type  1 
single countable object X elementary entity x SI; 1, 2 
count of X in sample s NX number of entities X x  SI; 2 
mass of X in sample s  mX mX = MNX∙NX  kg  SI; 3 
mass per single entity X MNX MNX = mX∙NX-1 kg∙x-1 1, 3 
Mitochondria  mt     
quantity of mt-elementary 
 marker in sample s 
 
mtE 
 
 
 
mtEU 
 
Concentrations     
molar concentration of B cB cB = nB∙V-1  mol∙L-1 SI 
count concentration of X CX CX = NX∙V-1  x∙L-1 SI; 4 
sample-mass concentration Cms Cms = ms∙V-1  kg∙L-1 4 
mitochondrial concentration CmtE CmtE = mtE∙V-1  mtEU∙L-1 5 
specific mitochondrial density DmtE DmtE = mtE∙ms-1  mtEU∙kg-1 1, 6 
mitochondrial content per X mtENX mtENX = mtE∙NX-1 mtEU∙x-1 7 
O2 flow and flux    8 
flow, system IO2 internal flow mol∙s-1 9 
volume-specific flux JV,O2 JV,O2 = IO2∙V-1 mol∙s-1∙L-1 1, 10 
flow per entity X IO2/X IO2/X = JV,O2∙CX-1 mol∙s-1∙x-1 11 
Sample mass-specific flux JO2/ms JO2/ms = JV,O2∙Cms-1 mol∙s-1∙kg-1 1 
mt-marker-specific flux JO2/mtE JO2/mtE = JV,O2∙CmtE-1 mol∙s-1∙mtEU-1 12 
1 A sample or subsample s is one or more parts taken from a study group. A sample s may contain countable objects X. 
Quantities (ms or Vs) that relate to a diluted sample have to be distinguished from quantities for the theremodynamic 
system (m or V; total mass or volume of the total contents in the instrumental chamber). See Table 5 for sample types. 
2 Entities X have to be specified, indicated by a subscript, NX (Nce; Norg; Nprotein). A single entity X is distinguished from a 
number NX of entities and from a sample s(X) containing X (Table 5). Entity X contains 1 x by definition. NX is the SI 
quantity ‘count’ [11]. The counting unit [x] as the unit of count is not used in the SI [95]. 
3 ms  = mX if s contains countable objects. Units are given in the MKSA system (Box 2). Prefix k is used for the SI base 
unit of mass (1 kg = 1,000 g). In praxis, various SI prefixes are used to make numbers easily readable, e.g., 1 mg tissue, 
cell or mitochondrial mass instead of 0.000001 kg. The units [kg∙x-1] and [kg] distinguish mass per object, MNX [kg∙x-1] 
(per single cell for X = ce;) from the mass mce [kg] of a sample of cells that contains any number of cells. 
4 IUPAC [24] uses the term ‘number concentration’ for CB. For X = ce, the cell-count concentration is Cce = Nce∙V-1. The SI 
quantity mass density ρ relates to a pure sample S, ρ = mS∙VS-1, in contrast to Cms = ms∙V-1 with diluted sample s. 
5 mt-concentration is the experimental variable of sample concentration in the chamber: (1) CmtE = mtE∙V-1; (2) CmtE = 
mtENX∙CX; (3) CmtE = DmtE∙Cms. 
6 If the amount of mitochondria mtE is expressed as mitochondrial mass, then DmtE is the mass fraction of mitochondria 
in the sample. If mtE is expressed as mitochondrial volume Vmt and normalized for the volume of sample Vs, then the 
volume fraction Φmts is obtained of mitochondria in sample s. 
7 mt-content mtENce per single cell equals mtE per cell count Nce, mtENce = mtE∙Nce-1 = CmtE∙Cce-1. 
8 O2 can be replaced by other chemicals to study different reactions, e.g., ATP, H2O2, or vesicular compartmental 
translocations, e.g., Ca2+. 
9 IO2 and V are defined per instrumental chamber as a system of constant volume (and typically constant temperature), 
which may be closed or open (Figure 5). IO2 is abbreviated for IrO2, i.e., the metabolic internal O2 flow of the chemical 
reaction sequence r in which O2 is consumed, hence the negative stoichiometric number, νO2 = -1. IrO2 = drnO2/dt∙νO2-1. 
If r includes all chemical reactions in which O2 participates, then drnO2 = dnO2 – denO2, where dnO2 is the change in the 
amount of O2 in the instrumental chamber and denO2 is the amount of O2 added externally to the system. At steady state 
in oxystat mode, by definition dnO2 = 0, hence drnO2 = –denO2. Note that in this context ‘external’, e, refers to the 
instrumental system, whereas in respiratory physiology ‘external’, ext, refers to the organism (See Overview). 
10 JV,O2 is an experimental variable, expressed per volume of the instrumental chamber.  
11 IO2/X is a physiological variable, depending on the size (mass or volume) of entity X. The unit for flow IO2 (instrumental 
system) is [mol∙s-1] (Note 9) versus [mol∙s-1∙x-1]  for flow per object IO2/X (Figure 5). 
12 There are many ways to normalize for a mitochondrial marker, that are used in different experimental approaches: 
(1) JO2/mtE = JV,O2∙CmtE-1; (2) JO2/mtE = JV,O2∙Cms-1∙DmtE-1 = JO2/ms∙DmtE-1; (3) JO2/mtE = JV,O2∙CX-1∙mtENX-1 = IO2/X∙mtENX-1; (4) JO2/mtE = 
IO2∙mtE-1. The mt-elementary unit [mtEU] varies depending on the mt-marker mtE. 
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count concentration of cells, Cce = Nce∙V-1. The 
total cell count is the sum of viable and dead 
cells, Nce = Nvce+Ndce (Table 5). The cell 
viability index, VI = Nvce∙Nce-1, is the ratio of 
the number of viable cells Nvce, per count of 
all cells in the population. After experimental 
permeabilization, all cells are permeabilized, 
Npce = Nce. The cell viability index can be used 
to normalize respiration for the number of 
cells that have been viable before 
experimental permeabilization, IO2/vce = 
IO2/ce∙VI-1, considering that mitochondrial 
respiratory dysfunction in dead cells might 
be a confounding factor. 
 
4.2. Size-specific flux: per sample size 
 
4.2.1. Sample concentration Cms [kg∙L-1]: 
Considering permeabilized tissue, 
homogenate or cells as the sample s, the 
sample mass ms [mg] is frequently measured 
as wet or dry mass, mw or md [mg], 
respectively, or as mass of protein mProtein. 
The sample-mass concentration is the mass 
of the (sub)sample per volume of the 
instrumental chamber, Cms = ms∙V-1 [g∙L-1 = 
mg∙mL-1]. Sample types s are isolated 
mitochondria, tissue homogenate, 
permeabilized muscle fibers or cells (Table 
4). mce [mg] is the total mass of all cells (s=ce) 
in an instrumental chamber, whereas MNce = 
mce∙Nce-1 [mg∙x-1] is the average mass per 
single cell (X=ce; Table 5 and Figure 5). 
4.2.2. Size-specific flux: Cellular O2 flow 
can be compared between cells of identical 
size. To take into account changes and 
differences in cell size, normalization is 
required to obtain cell size-specific or 
mitochondrial marker-specific O2 flux [113] 
(Figure 5).  
 
• Sample mass-specific flux JO2/ms 
[mol∙s-1∙kg-1]: Sample mass-specific flux is 
the expression of respiration per mass ms 
of sample s [mg]. Divide chamber volume-
specific flux JV,O2 by mass concentration of 
sample in the chamber, JO2/ms = JV,O2∙Cms-1. 
Cell mass-specific flux is obtained by 
dividing flow per cell by mass per cell, 
JO2/ms = IO2/X∙MNX-1.  
• Cell volume-specific flux JO2/Vs 
[mol∙s-1∙L-1]: Sample volume-specific flux 
is obtained by expressing respiration per 
volume of sample. 
 
 If size-specific O2 flux is constant and 
independent of sample size, then there is no 
interaction between the subsystems. For 
example, 1.5 mg and 3.0 mg sub-samples of  
muscle tissue respire at identical mass-
specific flux. If mass-specific O2 flux,   
however, changes as a function of the mass of 
a tissue sample, cells or isolated 
mitochondria in the instrumental chamber, 
then the nature of the interaction becomes 
an issue. Therefore, cell concentration must 
be optimized, particularly in experiments 
Table 5. Sample types s, or single elementary entities X 
 
Identity of sample or entitya s X Count Massb MNX Volume VNX 
mitochondrial preparation  [x] NX [x] ms [kg] [kg∙x-1] Vs [L] [L∙x-1] 
isolated mitochondria imt mt Nmt mimt MNmt Vimt VNmt 
tissue homogenate thom   mthom     
permeabilized tissue pti   mpti    
permeabilized muscle fibers pfi   mpfi    
permeabilized cells pce pce Npce mpce  MNpce Vpce VNpce 
living cellsc ce ce Nce mce  MNce Vce VNce 
viable cells  vce Nvce mvce  MNvce Vvce VNvce 
dead cells  dce Ndce mdce  MNdce Vdce VNdce 
organisms  org org Norg morg  MNorg Vorg VNorg 
moleculesd B B NB mB MNB VB VNB 
a A sample s may contain any number of entities X; entity X is the single defining object of the sample type. 
b ms [kg] is mass of the sample; MNX = ms∙NX-1 [kg∙x-1] is mass per single object (Table 4). Protein mass, wet mass mw, dry 
mass md, or ash-free dry mass maf, have to be specified [56]. 
c Total cell count in a living cell population, which consists of viable and dead cells, Nce = Nvce + Ndce, without experimental 
permeabilization of the plasma membrane. Living cells have been called ‘intact’ cells in contrast to permeabilized cells; 
but injured cells have lost the property of being intact, yet may still be living. 
d  IUPAC uses for MNB the term ‘mass of entity (molecule, formula unit)’ with symbol mf [24], but it should be ‘mass per 
entity’, MNB=mB∙NB-1. VB is the volume of molecules B, and the molecular volume is VNB=VB∙NB-1 (compare molar volume). 
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carried out in wells, considering the 
confluency of the cell monolayer or clumps of 
cells [121]. 
 The complexity changes when 
considering the scaling law of respiratory 
physiology. Strong interactions are revealed 
between O2 flow and body mass M of an 
individual organism: basal metabolic rate  
(flow) does not increase linearly with body 
mass. Maximum mass-specific O2 flux, ?̇?O2max 
or ?̇?O2peak, depends less strongly on 
individual body mass compared to basal 
metabolic flux [139]. Individuals, breeds and 
species deviate substantially from the 
common scaling relationship. ?̇?O2peak of 
human endurance athletes is 60 to 80 mL 
O2·min-1·kg-1 body mass, converted to 
JO2peak/M = IO2peak/org∙M-1 of 45 to 60 nmol·s-1·g-1 
[54] (Table 6). 
 
4.3. Marker-specific flux: per mitochondrial 
content 
 
Tissues can contain multiple cell populations 
that may have distinct mitochondrial 
subtypes. Mitochondria undergo dynamic 
fission and fusion cycles, and can exist in 
multiple stages and sizes that may be altered 
by a range of factors. The isolation of 
mitochondria (often achieved through 
differential centrifugation) can therefore 
yield a subsample of the mitochondrial types 
present in a tissue, depending on the 
isolation protocols utilized. This possible 
bias should be taken into account when 
planning experiments using isolated 
mitochondria. Different sizes of 
mitochondria are enriched at specific 
centrifugation speeds, which can be used 
strategically for isolation of mitochondrial 
subpopulations. 
 Part of the mitochondrial content of a 
tissue is lost during preparation of isolated 
mitochondria. The fraction of isolated 
mitochondria obtained from a tissue sample 
is expressed as mitochondrial recovery. At a 
high mitochondrial recovery, the fraction of 
isolated mitochondria is more 
representative of the total mitochondrial 
population than in preparations 
characterized by low recovery. 
Determination of the mitochondrial recovery 
and yield is based on measurement of the 
concentration of a mitochondrial marker in 
the stock suspension of isolated 
mitochondria, CmtE,stock, and crude tissue 
homogenate, CmtE,thom, which together 
provide information on the specific 
mitochondrial density in the sample, DmtE 
(Table 4). 
 When discussing concepts of 
normalization, it is essential to consider the 
question posed by the study. If the study 
aims at comparing tissue performance—
such as the effects of a treatment on a specific 
tissue, then normalization for tissue mass or 
protein content is appropriate. However, if 
the aim is to find differences in 
mitochondrial function independent of 
mitochondrial density (Table 4), then 
normalization to a mitochondrial marker is 
imperative (Figure 5). One cannot assume 
that quantitative changes in various 
markers—such as mitochondrial proteins—
necessarily occur in parallel with one 
another. It should be established that the 
marker chosen is not selectively altered by 
the performed treatment. In conclusion, the 
normalization must reflect the question 
under investigation to reach a satisfying 
answer. On the other hand, the goal of 
comparing results across projects and 
institutions requires standardization on 
normalization for entry into a databank. 
 
4.3.1. Mitochondrial concentration CmtE 
and mitochondrial markers: 
Mitochondrial organelles compose a 
dynamic cellular reticulum in various states 
of fusion and fission. Hence, the definition of 
an ‘amount’ of mitochondria is often 
misconceived: mitochondria cannot be 
counted reliably as a number of occurring 
elementary components. Therefore, 
quantification of the amount of mitochondria 
depends on the measurement of chosen 
mitochondrial markers. ‘Mitochondria are 
the structural and functional elementary units 
of cell respiration’ [54]. The quantity of a 
mitochondrial marker can reflect the amount 
of mitochondrial elementary components, 
mtE, expressed in various mitochondrial 
elementary units [mtEU] specific for each 
measured mt-marker (Table 4). However, 
since mitochondrial quality may change in 
response to stimuli—particularly in 
mitochondrial dysfunction [15], exercise 
training [105], and aging [29]—some 
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markers can vary while others are 
unchanged: (1) Mitochondrial volume and 
membrane area are structural markers, 
whereas mitochondrial protein mass is 
commonly used as a marker for isolated 
mitochondria. (2) Molecular and enzymatic 
mitochondrial markers (amounts or 
activities) can be selected as matrix markers, 
e.g., citrate synthase activity, mtDNA; mtIM-
markers, e.g., cytochrome c oxidase activity, 
aa3 content, cardiolipin, or mtOM-markers, 
e.g., the voltage-dependent anion channel 
(VDAC), TOM20. (3) Extending the 
measurement of mitochondrial marker 
enzyme activity to mitochondrial pathway 
capacity, ET- or OXPHOS-capacity can be 
considered as an integrative functional 
mitochondrial marker. 
 Depending on the type of mitochondrial 
marker, the mitochondrial elementary entity 
mtE is expressed in marker-specific units. 
Mitochondrial concentration in the 
instrumental chamber and mitochondrial 
density in the tissue of origin are quantified 
as (1) the quantity CmtE for normalization in 
functional analyses, and (2) the physiological 
output DmtE that is the result of mitochondrial 
biogenesis and degradation, respectively 
(Table 4). It is recommended, therefore, to 
distinguish experimental mitochondrial 
concentration, CmtE = mtE∙V-1 and 
physiological mitochondrial density, DmtE = 
mtE∙ms-1. Then mitochondrial density is the 
amount of mitochondrial elementary 
components per mass of tissue, which is a 
biological variable (Figure 5). The 
experimental variable, CmtE = DmtE∙Cms, is 
mitochondrial density multiplied by sample 
mass concentration in the measuring 
chamber, or is CmtE = mtENX∙CX, mitochondrial 
content multiplied by sample-count 
concentration (Table 4). 
 
4.3.2. mt-Marker-specific flux JO2/mtE: 
Volume-specific metabolic O2 flux depends 
on: (1) the sample concentration in the 
volume of the instrumental chamber, Cms or 
CX; (2) the mitochondrial density in the 
sample, DmtE = mtE∙ms-1 or mtENX = mtE∙NX-1; 
and (3) the specific mitochondrial activity or 
performance per mitochondrial elementary 
marker, JO2/mtE = JV,O2∙CmtE-1 [mol∙s-1∙mtEU-1] 
(Table 4). Obviously, the numerical results 
and variability of JO2/mtE vary with the type of 
mitochondrial marker chosen for 
measurement of mtE and CmtE = mtE∙V-1 
[mtEU∙L-1]. 
 Different methods for the quantification 
of mitochondrial markers have different 
strengths and weaknesses. Some problems 
are common for all mitochondrial markers 
mtE: (1) Accuracy of measurement is crucial, 
since even a highly accurate and 
reproducible measurement of chamber 
volume-specific O2 flux results in an 
inaccurate and noisy expression if 
normalized by a biased and noisy 
measurement of a mitochondrial marker. 
This problem is acute in mitochondrial 
respiration because the denominators used 
(the mitochondrial markers) are often small 
moieties of which accurate and precise 
determination is difficult. In contrast, an 
internal marker is used when O2 fluxes 
measured in substrate-uncoupler-inhibitor 
titration protocols are normalized for flux in 
a defined respiratory reference state within 
the assay, which yields flux control ratios 
FCR. FCRs are independent of externally 
measured markers and, therefore, are 
statistically robust, considering the 
limitations of ratios in general [62]. FCRs 
indicate qualitative changes of 
mitochondrial respiratory control, with 
highest quantitative resolution, separating 
the effect of mitochondrial density on JO2/ms 
and IO2/X from that of function per 
mitochondrial elementary marker, JO2/mtE 
[54; 105]. (2) If mitochondrial quality does 
not change and only the amount of 
mitochondria varies as a determinant of 
mass-specific flux, any marker is equally 
qualified in principle; then in practice 
selection of the optimum marker depends 
only on the accuracy and precision of 
measurement of the mitochondrial marker. 
(3) If mitochondrial flux control ratios 
change, then there may not be any best 
mitochondrial marker. In general, 
measurement of multiple mitochondrial 
markers enables a comparison and 
evaluation of normalization for these 
mitochondrial markers. Particularly during 
postnatal development, the activity of 
marker enzymes—such as cytochrome c 
oxidase and citrate synthase—follows 
different time courses [34]. Evaluation of 
mitochondrial markers in healthy controls is 
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insufficient for providing guidelines for 
application in the diagnosis of pathological 
states and specific treatments [125]. 
 In line with the concept of the respiratory 
acceptor control ratio [19], the most readily 
applied normalization is that of flux control 
ratios and flux control factors [53; 54]. Then, 
instead of a specific mt-enzyme activity, the 
respiratory rate in a reference state serves as 
the mtE, yielding a nondimensional ratio of 
two fluxes measured consecutively in the 
same respirometric titration protocol. 
Selection of the state of maximum flux in a 
protocol as the reference state ― e.g., ET-
state in L/E and P/E flux control ratios [53] 
― has the advantages of: (1) elimination of 
experimental variability in additional 
measurements, such as determination of 
enzyme activity or tissue mass; (2) 
statistically validated linearization of the 
response in the range of 0 to 1; and (3) 
consideration of maximum flux for 
integrating a large number of metabolic 
steps in the OXPHOS- or ET-pathways. This 
reduces the risk of selecting a functional 
marker that is specifically altered by the 
treatment or pathology, yet increases the 
chance that the highly integrative pathway is 
disproportionately affected, e.g., the 
OXPHOS- rather than ET-pathway in case of 
an enzymatic defect in the phosphorylation-
pathway. In this case, additional information 
can be obtained by reporting flux control 
ratios based on a reference state that 
indicates stable tissue mass-specific flux 
[125].  
 Stereological measurement of 
mitochondrial content via two-dimensional 
transmission electron microscopy is 
considered as the gold standard in 
determination of mitochondrial volume 
fractions in cells and tissues [139]. Accurate 
determination of three-dimensional volume 
by two-dimensional microscopy, however, is 
both time consuming and statistically 
challenging [73]. The validity of using 
mitochondrial marker enzymes (citrate 
synthase activity, CI to CIV amount or 
activity) for normalization of flux is limited 
in part by the same factors that apply to flux 
control ratios. Strong correlations between 
various mitochondrial markers and citrate 
synthase activity [8; 94; 112] are expected in 
a specific tissue of healthy persons and in 
disease states not specifically targeting 
citrate synthase. Citrate synthase activity is 
acutely modifiable by exercise [76; 132]. 
Evaluation of mitochondrial markers related 
to a selected age and sex cohort cannot be 
extrapolated to provide recommendations 
for normalization in respirometric diagnosis 
of disease, in different states of development 
and aging, different cell types, tissues, and 
species. mtDNA normalized to nDNA via 
qPCR is correlated to functional 
mitochondrial markers including OXPHOS- 
and ET-capacity in some cases [8; 36; 88; 
108; 137], but lack of such correlations have 
been reported [90; 105; 126]. Several studies 
indicate a strong correlation between 
cardiolipin content and increase in 
mitochondrial function with exercise [40; 
73; 89; 90], but it has not been evaluated as a 
general mitochondrial biomarker in disease. 
With no single best mitochondrial marker, a 
good strategy is to quantify several different 
biomarkers to minimize the decorrelating 
effects caused by diseases, treatments, or 
other factors. Determination of multiple 
markers, particularly a matrix marker and a 
marker from the mtIM, allows tracking 
changes in mitochondrial quality defined by 
their ratio. 
 
5. Normalization of rate per system 
 
5.1. Flow: per chamber 
 
The instrumental system (chamber) is part 
of the measurement instrument, separated 
from the environment as a closed, open, 
isothermal or non-isothermal system  
(Table 4). Reporting O2 flows per 
respiratory chamber, IO2 [nmol∙s-1], restricts 
the analysis to intra-experimental 
comparison of relative differences. 
 
5.2. Flux: per chamber volume 
 
5.2.1. System-specific flux JV,O2: We 
distinguish between (1) the system with 
volume V and mass m defined by the system 
boundaries and its total contents, and (2) the 
sample with volume Vs and mass ms enclosed 
in the instrumental chamber (Figure 5). 
Metabolic O2 flow per object, IO2/X, is the total 
O2 flow in the system divided by the number 
of objects, NX, in the system. IO2/X increases as 
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the mass MNX of the object is increased. 
Sample mass-specific O2 flux, JO2/ms, should be 
independent of the mass-concentration of 
the subsample obtained from the same tissue 
or cell culture, but system volume-specific O2 
flux JV,O2 (per liquid volume of the 
instrumental chamber) increases in 
proportion to the mass of the sample in the 
chamber. Although JV,O2 depends on mass-
concentration of the sample in the chamber, 
it should be independent of the chamber 
(system) volume at constant sample mass- 
concentration. There are practical 
limitations to increasing the mass-
concentration of the sample in the chamber, 
when one is concerned about crowding 
effects and instrumental time resolution. The 
wall of the chamber and the enclosed solid 
stirrer are not counted as part of the chamber 
volume. 
 
5.2.2. Advancement per volume: When the 
reactor volume does not change during the 
reaction, which is typical for liquid phase 
reactions, the volume-specific flux of a 
chemical reaction r is the time derivative of 
the advancement of the reaction per unit 
volume, JV,rB = drξB/dt∙V-1 [(mol∙s-1)∙L-1]. The 
rate of concentration change is dcB/dt  
[(mol∙L-1)∙s-1], where concentration is cB = 
nB∙V-1. There is a difference between (1) JV,rO2 
[mol∙s-1∙L-1] and (2) rate of concentration 
change [mol∙L-1∙s-1]. These merge into a 
single expression only in closed systems. In 
open systems, internal transformations 
(catabolic flux, O2 consumption) are 
distinguished from external flux (such as O2 
supply). External fluxes of all substances are 
zero in closed systems. In a closed chamber 
O2 consumption (internal flux of catabolic 
reactions k; IkO2 [pmol∙s-1]) causes a decline 
in the amount of O2 in the system, nO2 [nmol]. 
Normalization of these quantities for the 
volume of the system, V [L], yields volume-
specific O2 flux, JV,kO2 = IkO2/V [nmol∙s-1∙L-1], 
and O2 concentration, [O2] or cO2 = nO2∙V-1 
[µmol∙L-1 = µM = nmol∙mL-1]. Instrumental 
background O2 flux is due to external flux 
into a non-ideal closed respirometer, so total 
volume-specific flux has to be corrected for 
instrumental background O2 flux—O2 
diffusion into or out of the instrumental 
Table 6. Conversion of various formats and units used in respirometry and ergometry 
to SI units (International System of Units). e- is the number of electrons or reducing 
equivalents. zB is the charge number of entity B. 
 
Format 1 Unit                                   ∙ Multiplication factor SI-unit  Notes 
n  ng.atom O∙s-1 (2 e-) 0.5 nmol O2∙s-1  
n  ng.atom O∙min-1 (2 e-) 8.333 pmol O2∙s-1  
n  natom O∙min-1 (2 e-) 8.333 pmol O2∙s-1  
n  nmol O2∙min-1 (4 e-) 16.67 pmol O2∙s-1  
n  nmol O2∙h-1 (4 e-) 0.2778 pmol O2∙s-1  
V to n mL O2∙min-1 at STPDa 0.7443 µmol O2∙s-1 1 
e to n W = J/s at -470 kJ/mol O2 -2.128 µmol O2∙s-1  
e to n mA = mC∙s-1  (zH+ = 1) 10.36 nmol H+∙s-1 2 
e to n mA = mC∙s-1  (zO2 = 4) 2.591 nmol O2∙s-1 2 
n to e nmol H+∙s-1  (zH+ = 1) 0.09649 mA 3 
n to e nmol O2∙s-1  (zO2 = 4) 0.3859 mA 3 
1 At standard temperature and pressure dry (STPD: 0 °C = 273.15 K and 1 atm = 101.325 
kPa = 760 mmHg), the molar volume of an ideal gas Vm is 22.414 and Vm,O2 is 22.392 
L∙mol-1. Rounded to three decimal places, both values yield the conversion factor of 
0.744. For comparison at normal temperature and pressure dry (NTPD: 20 °C), Vm,O2 is 
24.038 L∙mol-1. Note that the SI standard pressure is 100 kPa. 
2 The multiplication factor is 106/(zB∙F). 
3 The multiplication factor is zB∙F/106. 
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chamber. JV,kO2 is relevant mainly for 
methodological reasons and should be 
compared with the accuracy of instrumental 
resolution of background-corrected flux, e.g., 
±1 nmol∙s-1∙L-1 [51]. ‘Catabolic’ indicates O2 
flux, JkO2, corrected for: (1) instrumental 
background O2 flux; (2) chemical 
background O2 flux due to autoxidation of 
chemical components added to the 
incubation medium; and (3) Rox for O2-
consuming side reactions unrelated to the 
catabolic pathway k. 
 
6. Conversion of units 
 
Many different units have been used to 
report the O2 consumption rate OCR (Table 
6). SI base units provide the common 
reference to introduce the theoretical 
principles (Figure 5), and are used with 
appropriately chosen SI prefixes to express 
numerical data in the most practical format, 
with an effort towards unification within 
specific areas of application (Table 7). 
Reporting data in SI units—including the 
mole [mol], coulomb [C], joule [J], and second 
[s]—should be encouraged, particularly by 
journals that propose the use of SI units. 
 Although volume is expressed as m3 using 
the SI base unit, the liter [dm3] is a 
conventional unit of volume for 
concentration and is used for most solution 
chemical kinetics. If one multiplies IO2/X by CX, 
then the result will not only be the amount of 
O2 [mol] consumed per time [s-1] in one liter 
[L-1], but also the change in O2 concentration 
per second (for any volume of an ideally 
closed system). This is ideal for kinetic 
modeling as it blends with chemical rate 
equations where concentrations are 
typically expressed in mol∙L-1 [136]. In 
studies of multinuclear cells—such as 
differentiated skeletal muscle cells—it is 
easy to determine the number of nuclei but 
not the total number of cells. A generalized 
concept, therefore, is obtained by 
substituting cells by nuclei as the sample 
entity. This does not hold, however, for non-
nucleated platelets. 
 For studies of cells, we recommend that 
respiration be expressed, as far as possible, 
as: (1) O2 flux normalized for a mitochondrial 
marker, for separation of the effects of 
mitochondrial quality and content on cell 
respiration (this includes FCRs as a 
normalization for a functional mitochondrial 
marker); (2) O2 flux in units of cell volume or 
mass, for comparison of respiration of cells 
with different cell size [113] and with studies 
on tissue preparations, and (3) O2 flow in 
units of attomole (10-18 mol) of O2 consumed 
per second by each individual cell 
[amol∙s-1∙x-1], numerically equivalent to 
[pmol∙s-1∙(106 x)-1]. This convention allows 
information to be easily used when 
designing experiments in which O2 flow must 
be considered. For example, to estimate the 
volume-specific O2 flux in an instrumental 
chamber that would be expected at a 
particular cell-count concentration, one 
simply needs to multiply the flow per cell by 
the number of cells per volume of interest. 
This provides the amount of O2 [mol] 
consumed per time [s-1] per unit volume 
[L-1]. At an O2 flow of 100 amol∙s-1∙x-1 and a 
cell-count concentration of 109 x∙L-1 (= 106 
x∙mL-1), the chamber volume-specific O2 flux 
is 100 nmol∙s-1∙L-1 (= 100 pmol∙s-1∙mL-1). 
 ET-capacity in human cell types including 
HEK 293, primary HUVEC, and fibroblasts 
ranges from 50 to 180 amol∙s-1∙x-1, measured 
in living cells in the noncoupled state [54]. At 
100 amol∙s-1∙x-1 corrected for Rox, the 
current across the mt- membranes, IH+e, 
approximates 193 pA∙x-1 or 0.2 nA per cell. 
See Rich [115] for an extension of 
quantitative bioenergetics from the 
molecular to the human scale, with a 
transmembrane proton flux equivalent to 
520 A in an adult at a catabolic power of -110 
W∙x-1. Modelling approaches illustrate the 
link between protonmotive force and 
currents [143]. 
 We consider isolated mitochondria as 
powerhouses and proton pumps as 
molecular machines to relate experimental 
results to energy metabolism of living cells. 
The cellular P»/O2 based on oxidation of 
glycogen is increased by the glycolytic 
(fermentative) substrate-level 
phosphorylation of 3 P»/Glyc or 0.5 mol P» 
for each mol O2 consumed in the complete 
oxidation of a mol glycosyl unit (Glyc). 
Adding 0.5 to the mitochondrial P»/O2 ratio 
of 5.4 yields a bioenergetic cell physiological 
P»/O2 ratio close to 6. Two NADH 
equivalents are formed during glycolysis and 
transported from the cytosol into the 
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mitochondrial matrix, either by the malate-
aspartate shuttle or by the glycerophosphate 
shuttle (Figure 1a) resulting in different 
theoretical yields of ATP generated by 
mitochondria, the energetic cost of which 
potentially must be taken into account. 
Considering also substrate-level 
phosphorylation in the TCA cycle, this high 
P»/O2 ratio not only reflects proton 
translocation and OXPHOS studied in 
isolation, but integrates mitochondrial 
physiology with energy transformation in 
the living cell [49]. 
 
7. Conclusions 
 
Catabolic cell respiration is the process of 
exergonic and exothermic energy 
transformation in which scalar redox 
reactions are coupled to vectorial ion 
translocation across a semipermeable 
membrane, which separates the small 
volume of a bacterial cell or mitochondrion 
from the larger volume of its surroundings. 
The electrochemical exergy can be partially 
conserved in the phosphorylation of ADP to 
ATP or in ion pumping, or dissipated in an 
electrochemical short-circuit. Respiration is 
thus clearly distinguished from fermentation 
as the counterparts of cellular core energy 
metabolism. O2 flux balance schemes 
illustrate the relationships and general 
definitions (Overview, Figure 1). 
 Experimentally, respiration is separated 
in mitochondrial preparations from the 
interactions with the fermentative pathways 
of the living cell. OXPHOS analysis is based on 
the study of mitochondrial preparations 
complementary to bioenergetic 
investigations of (1) submitochondrial 
particles and molecular structures, (2) living 
cells, and (3) organisms—from model 
organisms to the human species including 
healthy and diseased persons (patients). 
 
 
Box 3: Recommendations for studies 
with mitochondrial preparations 
 
● Normalization of respiratory rates should 
be provided as far as possible:  
 
A. Sample normalization 
 
1.  Object number-specific biophysical 
normalization: on a per number of 
organism or cell basis as O2 flow; this may 
Table 7. Conversion of units with preservation of numerical values. 
Name Frequently used unit Equivalent unit Notes 
volume-specific flux JV,O2 pmol∙s-1∙mL-1 nmol∙s-1∙L-1 1 
 mmol∙s-1∙L-1 mol∙s-1∙L-3 2 
flow per cell IO2/ce pmol∙s-1∙Mx-1 amol∙s-1∙x-1 3 
 pmol∙s-1∙Gx-1 zmol∙s-1∙x-1 4 
cell-count concentration Cce  106 cells∙mL-1 109 cells∙L-1  
mitochondrial protein concentration CmtE 0.1 mg∙mL-1 0.1 g∙L-1  
Sample mass-specific flux JO2/ms pmol∙s-1∙mg-1 nmol∙s-1∙g-1 5 
catabolic power Pk µW∙Mx-1 pW∙x-1 1, 3 
volume V  1,000 L m3 (1,000 kg)  
 L dm3 (kg)  
 mL cm3 (g)  
 µL mm3 (mg)  
 fL µm3 (pg) 6 
amount of substance concentration, nB M = mol∙L-1 mol∙dm-3  
1 pmol: picomole = 10-12 mol 4 zmol: zeptomole = 10-21 mol; 1 Gx = 109 x 
2 mmol: millimole = 10-3 mol 5 nmol: nanomole = 10-9 mol 
3 amol: attomole = 10-18 mol; 1 Mx = 106 x 6 fL: femtoliter = 10-15 L; µL: microliter = 10-6 L 
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not be possible when dealing with 
coenocytic organisms, e.g., filamentous 
fungi, or tissues without cross-walls 
separating individual cells, e.g., muscle 
fibers. 
2. Size-specific cellular normalization: per g 
protein; per organism-, cell- or tissue-
mass as mass-specific O2 flux; per cell 
volume as cell volume-specific flux. 
3. Mitochondrial normalization: per 
mitochondrial marker as mt-specific flux.  
 
B. Chamber normalization 
 
1.  Chamber volume-specific flux JV 
[pmol∙s-1∙mL-1] is reported for quality 
control in relation to instrumental 
sensitivity and limit of detection of 
volume-specific flux. 
2. Sample concentration in the instrumental 
chamber is reported as count 
concentration, mass concentration, or 
mitochondrial concentration; this is a 
component of the measuring conditions. 
With information on cell size and the use 
of multiple normalizations, maximum 
potential information is available [54; 
113; 136]. Reporting exclusively flow in a 
respiratory chamber [nmol∙s-1] is 
discouraged, since it restricts the analysis 
to intra-experimental comparison of 
relative (qualitative) differences.  
 
● Catabolic mitochondrial respiration is 
distinguished from residual O2 
consumption. Fluxes in mitochondrial 
coupling states should be, as far as 
possible, corrected for residual O2 
consumption. 
 
● Different mechanisms of uncoupling 
should be distinguished by defined terms. 
The tightness of coupling relates to these 
uncoupling mechanisms, whereas the 
coupling stoichiometry varies as a 
function the substrate type involved in 
ET-pathways with either three or two 
redox proton pumps operating in series. 
Separation of tightness of coupling from 
the pathway-dependent coupling 
stoichiometry is possible only when the 
substrate type undergoing oxidation 
remains the same for respiration in 
LEAK-, OXPHOS-, and ET-states. In studies 
of the tightness of coupling, therefore, 
simple substrate-inhibitor combinations 
should be applied to exlcude a shift in 
substrate competition that may occur 
when providing physiological substrate 
cocktails. 
● In studies of isolated mitochondria, the 
mitochondrial recovery and yield should 
be reported. Experimental criteria such as 
transmission electron microscopy for 
evaluation of purity versus integrity 
should be considered. Mitochondrial 
markers—such as citrate synthase 
activity as an enzymatic matrix marker—
provide a link to the tissue of origin on the 
basis of calculating the mitochondrial 
recovery, i.e., the fraction of 
mitochondrial marker obtained from a 
unit mass of tissue. Total mitochondrial 
protein is frequently applied as a 
mitochondrial marker, which is restricted 
to isolated mitochondria. 
 
● In studies of permeabilized cells, the 
viability of the cell culture or cell 
suspension of origin should be reported. 
Normalization should be evaluated for 
total cell count or viable cell count. 
 
● Terms and symbols are summarized in 
Table 8. Their use will facilitate 
transdisciplinary communication and 
support further development of a 
consistent theory of bioenergetics and 
mitochondrial physiology. Technical 
terms related to and defined with normal 
words can be used as index terms in data 
repositories, support the creation of 
ontologies towards semantic information 
processing (MitoPedia), and help in 
communicating analytical findings as 
impactful data-driven stories. ‘Making 
data available without making it 
understandable may be worse than not 
making it available at all’ [99]. Success 
will depend on taking further steps: (1) 
exhaustive text-mining considering 
Omics data and functional data; (2) 
network analysis of Omics data with 
bioinformatics tools; (3) cross-validation 
with distinct bioinformatics approaches; 
(4) correlation with physiological data; 
(5) guidelines for biological validation of 
network data. This is a call to carefully 
contribute to FAIR principles (Findable, 
Accessible, Interoperable, Reusable) for 
the sharing of scientific data. 
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Table 8. Terms, symbols, and units. SI base units are used, except for the liter [L ≡ dm3]. SI 
refers to ref. [11]. 
 
 
Term Symbol Unit  Links and comments 
 
 
alternative quinol oxidase AOX  Fig. 1B 
adenosine monophosphate AMP  2 ADP ↔ ATP+AMP 
adenosine diphosphate ADP  Tab. 1; Fig. 1, 2, 5 
adenosine triphosphate ATP  Fig. 2, 5 
adenylates AMP, ADP, ATP Section 2.5.1 
amount of substance X nX or n(X) [mol] SI 
ATP yield per O2 YP»/O2  1 P»/O2 ratio measured in any 
respiratory state 
catabolic reaction k  Fig. 1, 3 
catabolic rate of respiration JkO2; IkO2 varies Fig. 1, 3; see flux J and flow I 
cell count Nce [x] Tab. 4; Fig. 5; see number of cells 
cell mass mce [kg] Tab. 5; Fig. 5 
cell mass, mass per cell MNce [kg∙x-1] Tab. 5; Fig. 5 
cell-mass concentration Cmce [kg∙L-1] see Cms; Tab. 4; Cmce = mce∙V-1 
cell-count concentration Cce [x∙L-1] Tab. 4; Cce = Nce∙V-1 
cell viability index VI  VI = Nvce∙Nce-1 = 1- Ndce∙Nce-1 
charge number of entity B zB  1 Tab. 6; zO2 = 4 [24] 
Complexes I to IV CI to CIV  respiratory ET Complexes are 
redox proton pumps; Fig. 1B; 
F1FO-ATPase is not a redox 
proton pump of the ETS, hence 
the term CV is not 
recommended 
concentration of X, count CX = NX∙V-1 [x∙L-1]  Tab. 4 (number concentration 
[24]) 
concentration of B, amount cB = nB∙V-1 [mol∙L-1]  SI: amount of substance 
concentration [24] 
concentration of O2, amount cO2 = nO2∙V-1 [mol∙L-1]  Box 2; [O2] 
count format N [x] Tab. 4, 5; Fig. 5 
count of X NX [x] SI; see number of entities X 
coupling control state CCS  Section 2.4.1 
dead cells dce  Tab. 5 
electrical format e [C] Tab. 6 
electron transfer, state ET  Tab. 1; Fig. 2B, 4 (State 3u) 
electron transfer system ETS  Fig. 2B, 4 (electron transport 
chain) 
entity X [x] single countable object; Tab. 4 
ET-capacity E varies rate; Tab. 1; Fig. 2 
ET-excess capacity E-P varies Fig. 2 
flow, for O2 IO2 [mol∙s-1]  system-related extensive 
quantity; Fig. 5 
flux, for O2 JO2 varies size-specific quantity; Fig. 5 
inorganic phosphate Pi  Fig. 1C 
inorganic phosphate carrier PiC  Fig. 1C 
isolated mitochondria imt  Tab. 5 
living cells ce  Tab. 5 (intact cells) 
LEAK-state  LEAK  Tab. 1; Fig. 2 (compare State 4) 
LEAK-respiration L varies rate; Tab. 1; Fig. 2 
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mass concentration of sample s Cms [kg∙L-1] Tab. 4 
mass format m [kg] Tab. 4 
mass of diluted sample ms [kg] SI: mass of pure sample mS 
mass per single object MNX [kg∙x-1] Fig. 5; Tab. 4; SI: m(X); compare 
molar mass M(X) 
mass, dry mass md [kg] Fig. 5 (dry weight) 
mass, wet mass mw [kg] Fig. 5 (wet weight) 
MITOCARTA  https://www.broadinstitute.org/scientific-
community/science/programs/
metabolic-disease-
program/publications/mitocarta
/mitocarta-in-0  
MitoPedia  http://www.bioblast.at/index.php/MitoPedia 
mitochondria or mitochondrial mt  Box 1 
mitochondrial DNA mtDNA  Box 1 
mitochondrial concentration CmtE = mtE∙V-1  [mtEU∙L-1]  Tab. 4 
mitochondrial content mtENX  [mtEU∙x-1]  mtENX = mtE∙NX-1; Tab. 4 
mitochondrial density DmtE=mtE∙ms-1 [mtEU∙kg-1] tissue mass-specific mt-density; 
Tab. 4 
mitochondrial  
 elementary marker mtE [mtEU] quantity of mt-marker; Tab. 4 
mitochondrial elementary unit mtEU varies  specific units for mt-marker; 
Tab. 4 
mitochondrial inner membrane  mtIM   Fig. 1; Box 1 (MIM) 
mitochondrial outer membrane  mtOM   Fig. 1; Box 1 (MOM) 
mitochondrial recovery YmtE  1 fraction of mtE recovered from 
the tissue sample in imt-stock 
mitochondrial yield YmtE/ms [mtEU∙kg-1] mt-yield in imt-stock per mass of 
tissue sample; YmtE/ms=YmtE∙DmtE 
molar format n [mol] Tab. 6 
molar mass MB [kg∙mol-1] compare MNB [kg∙x-1]; SI M(X) 
negative neg  Fig. 4 
number of cells Nce [x] total cell count of living cells, Nce 
= Nvce + Ndce; Tab. 4, 5 
number of dead cells Ndce [x] non-viable cell count, loss of 
plasma membrane barrier 
function; Tab. 5 
number of entities B NB [x] Tab. 4 [24] 
number of entities X; count NX [x]  ‘count’ is an SI quantity [11], but 
the counting unit [x] is not in 
the SI [95]; Tab. 4; Fig. 5 
number of viable cells Nvce [x] viable cell count, intact plasma 
membrane barrier function; 
Tab. 5 
organisms org [x] Tab. 5 
oxidative phosphorylation OXPHOS  Tab. 1 
OXPHOS-state OXPHOS  Tab. 1; Fig. 2; OXPHOS-state 
distinguished from the process 
OXPHOS (State 3 at kinetically-
saturating [ADP] and [Pi]) 
OXPHOS-capacity P varies rate; Tab. 1; Fig. 2 
oxygen concentration cO2 = nO2∙V-1 [mol∙L-1]  [O2]; Section 3.2 
oxygen flux, in reaction r JrO2 varies Overview 
pathway control state PCS  Section 2.2 
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permeability transition mtPT  Fig. 3; Section 2.4.3 (MPT) 
permeabilized cells pce  experimental permeabilization 
of plasma membrane; Tab. 5 
permeabilized muscle fibers pfi  Tab. 5 
permeabilized tissue pti  Tab. 5 
phosphorylation of ADP to ATP P»  Tab. 1, 2; Fig. 1, 4 
P»/O2 ratio P»/O2  1 mechanistic YP»/O2, calculated 
from pump stoichiometries; 
Fig. 1c 
positive pos  Fig. 4 
proton in the neg compartment H+neg [x] Fig. 4 
proton in the pos compartment H+pos [x] Fig. 4 
protonmotive force pmF [V] Overview; Tab. 1; Fig 1a, 2, 4 
rate in ET-state E varies ET-capacity; Tab. 1; Fig. 2, 4 
rate in LEAK-state L varies Tab. 1: L(n), L(T), L(Omy); Fig. 2 
rate in OXPHOS-state P varies OXPHOS-capacity; Tab.1; Fig. 2, 4 
rate in ROX state Rox varies Overview; Tab. 1 
residual oxygen consumption ROX; Rox  state ROX; rate Rox; Tab. 1 
respiration JrO2 varies rate of reaction r; Overview 
respiratory supercomplex SCInIIInIVn   supramolecular assemblies with 
variable copy numbers (n) of 
CI, CIII and CIV; Box 1 
sample s  diluted sample; Tab. 4, 5 
substrate concentration at  
 half-maximal rate c50 [mol∙L-1] Section 2.1.2 
substrate-uncoupler-inhibitor- 
 titration SUIT  Section 2.2 
tissue homogenate thom  Tab. 5 
viable cells vce  Tab. 5 
volume of chamber V [L] Tab. 4, 7; Fig. 5  
volume format V [L] Tab. 6 
volume of sample s Vs [L] Fig. 5; Tab. 5 
 
 
 
 Different mechanisms of respiratory 
uncoupling have to be distinguished (Figure 
3). Metabolic fluxes measured in defined 
coupling and pathway control states 
(Figures 1, 2 and 4) provide insights into 
the meaning of cellular and organismic 
respiration. 
 The optimal choice for expressing 
mitochondrial and cell respiration as O2 flow 
per biological sample, and normalization for 
specific tissue-markers (volume, mass, 
protein) and mitochondrial markers 
(volume, protein, content, mtDNA, activity of 
marker enzymes, respiratory reference 
state) is guided by the scientific question 
under study. Interpretation of the data 
depends critically on appropriate 
normalization (Figure 5). 
 Results are comparable between studies 
only, if respirometric measurements are 
normalized for defined quantities of sample. 
For some samples it is informative, if 
quantification is possible in terms of one or 
more entities (countable objects). Using cells 
as an example, a distinction is made between 
sample type (cells) and the quantity of cells 
(count, mass, volume). Using the unit 
[mol∙s-1∙cell-1] has been common but is 
ambiguous. This is resolved by (1) not only 
indicating the entity type (cell), but (2) 
additionally defining the quantity in which 
the entity is expressed (count, mass, volume) 
with corresponding units ([x], [kg], [L]). 
Similarly, substance concentrations (O2) can 
be expressed in various formats with 
corresponding units, including molecular 
count concentration, CO2 = NO2∙V-1 [x∙L-1], and 
molar amount concentration, cO2 = nO2∙V-1 
[mol∙L-1], whereas it does not make sense to 
write [O2∙L-1]. In conclusion, expressions 
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such as [cells∙L-1] or [mol∙s-1∙cell-1] should be 
replaced by [x∙L-1] or [mol∙s-1∙x-1]. Symbols 
for quantities, such as CX for count 
concentration, gain meaning only in context 
with specification of the entity (e.g., cell 
types, growth conditions). Simple symbols 
can be used (e.g., M for body mass [kg∙x-1], if 
clarity of definition is provided by the text. 
 MitoEAGLE can serve as a gateway to 
better diagnose mitochondrial respiratory 
adaptations and defects linked to genetic 
variation, age-related health risks, sex-
specific mitochondrial performance, lifestyle 
with its effects on degenerative diseases, and 
thermal and chemical environment. The 
present recommendations on coupling 
control states and rates are focused on 
studies using mitochondrial preparations 
(Box 3). These will be extended in a series of 
reports on pathway control of mitochondrial 
respiration, respiratory states and rates in 
living cells, respiratory flux control ratios, 
and harmonization of experimental 
procedures. 
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